JEAN EMOND

Compagnon depuis 1988
CURRICULUM VITAE:
Jean C. Emond
Date of Preparation:     Dec 15, 2018
Personal Data
Birthplace:                             El Pao, Venezuela
Citizenship:                United States of America
Academic Training
College:                                   University of Chicago, IL
1975(B.A.)
Medical School:                      University of Chicago,
                                                Pritzker School of Medicine July 1979        (M.D.)
Traineeship
Internship:                             University of Illinois, Chicago IL
General Surgery Cook County Hospital
July 1979- July 1980
Residency:                              University of Illinois, Chicago IL
General Surgery, Cook County Hospital
July 1980-July 1984
Fellowship:                 Hòpital Paul Brousse, Université de
Paris Sud Villejuif, France
Hepatobiliary Surgery
July 1984-July 1985
Fellowship:                 University of Chicago, Chicago IL
Liver Transplantation
July 1985-July 1987
Management training:          Management Institute for Clinical Chiefs
                                                Columbia School of Public Health
                                                Sept and Nov.  1998
Board Certification
National Board of Medical Examiners   June 1980
Professional Organization and Societies
American Association for the Study of Liver Diseases 1988
American College of Surgeons – Fellow 1989
American Society of Hepato-Pancreato-Biliary Surgery Founding Member
American Society of Transplant Surgeons 1987
Association for Academic Surgery 1988
Compagnons Hepato-Biliaire 1988
Howard C. Naffziger Surgical Society 1992
International Hepato-Biliary Pancreatic Association 1988
International Liver Transplantation Society 2000
Pacific Coast Surgical Association 1993
San Francisco Surgical Society 1992
Society for Surgery of the Alimentary Tract 1993
Societé International de Chirurgie 1990
Society of University Surgeons 1993
Warren H. Cole Society 1987
American Surgical Association 2002
University Appointments
Executive Director of Transplantation Initiative, Columbia University and The New York Presbyterian Hospital.  June 2007-present.
Vice Chair for Operations and Quality, Department of Surgery  Feb04-June/07.
Vice Chair and Chief of Transplantation Services, Department of Surgery  May 01-present.
Thomas S. Zimmer Professor of Reconstructive Surgery Endowed Chair Jan 2000.
Professor of Surgery (Tenure awarded) Columbia University College of Physicians and Surgeons.   July 97.
Professor of Surgery in Pediatrics. Columbia University College of Physicians and Surgeons  Jan 99.
Adjunct Professor of Surgery. The Joan and Sanford Weill School of Medicine.  Cornell University.   Sept 98 –present
Associate Professor in Residence, Department of Surgery, University of California, San Francisco.  July 1992-June 1997.
Visiting Associate Professor of Surgery, Harvard University, Boston Children’s Hospital.  October 1992.
Visiting Associate Professor of Surgery.  University of California, San Diego 1993
Assistant Professor of Surgery, University of Chicago, Pritzker School of Medicine, July 1987-June1992.
Hospital Appointments
Visiting Professor of Hepatobiliary Surgery Chinese PLA General Hospital Beijing China.  2013-2016
Medical Director Transplant Service Line, Columbia University,
The New York Presbyterian Hospital Sept 1998-present.
Surgical Director, Center for Liver Disease and Transplantation
The New York Presbyterian Hospital, New York
July 1997 – Jan 2004.
Division Chief, Liver Surgery and Transplantation
Columbia-University Medical Center
New York, New York July 1997-June 2005.
Consultant in Liver Transplantation
Northwestern University Medical Center and the Childrens’
Memorial Hospital, Chicago, IL   July 1997-June1998
Director, Pediatric Liver Transplantation: University of California, San Francisco
San Francisco, California  July 1992-June 1997
Transplant Surgeon:  California Pacific Medical Center
San Francisco, California  July 1995-June 1997
Director, Liver Transplantation & Hepatobiliary Surgery
University of Chicago, Pritzker School of Medicine
Chicago, Illinois July 1991-June 1992
Honors
Ray and Joan Kroc Travelling Scholarship
Eleanor B. Pillsbury Fellowship
French Government Post-Graduate Scholarship
Fulbright Travel Grant for International Study
Andrew Mellon Young Faculty Member
PEW Scholars Program-University of Chicago nominee
Honorary Faculty Member AOA
Named in The Best Doctors in America
Woodward/White, Inc.  1994-
Best Doctors in New York  (New York Magazine)1998-
Ellis Island Medal of Honor 2000
Doctor of the Year,  Latino Organization for liver awareness 2000
Physician Honoree,  TRIO Manhattan 2005.
Physician of the Year, American Liver Foundation 2013
Departmental and University Service
University of Chicago
Alumni Class Director, 1979-1992
Department of Surgery Quality Assurance Committee, 1992
Department of Surgery Resident Review Committee, 1989-1992
Medical Records Committee, 1990-1992
UCSF
Academic Affairs – Ad Hoc Review Committee for appointments promotions 1992-1997.
Donor Council –California Transplant Donor Network (CTDN), 1992-1997.
NIH Liver Center Executive Committee, 1995-1997
Course Director for Surgery (3rdyear clerkship), 1993-1997
Residency Recruitment Committee, Department of Surgery, 1995-1997
Residency Coordination and Review Committee (RCRC)
Department of Surgery, 1995-1997
Columbia College of Physicians and Surgeons
Hepatitis C Steering Committee Rockefeller University, 1997-1998
Leadership Committee Department of Surgery, 1997-present
Executive Transplant Committee, 1997-present
Internal GI Review Division Committee, 1997- 1998
Pediatric Surgery Chief, Search Committee 1998
Surgical Oncology Search Committee, Chair 1998.
Associate Program Director for Education   1998-2000
Vascular Surgery Search Committee 2000
Psychiatry Chair Search Committee 2002
Faculty practice organization: Space committee 2004
Faculty practice organization: Medical liability committee 2004.
FPO:  Disclosure subcommittee: Chair 2005.
Microbiology Chair:  Search Committee 2007
Pediatrics Chair:  Search Committee 2007
Psychiatry Chair: Search Committee 2007
Ad Hoc Committee on Scientific misconduct 2010
Academy of Clinical Mentoring and Excellence 2016.
Chair, Search Committee Department of Emergency Medicine 2017
Teaching:  UCSF
Course Director, General Surgery Clerkship, 1994-1997
Instructor, General Surgery Clerkship, 1994-1997
Instructor, Clinical Surgery Liver Transplantation, 1992-1997
Instructor, Clinical Research in Surgery, 1992-1997
Instructor, General Surgery Staff Conf. Surgery, 1992-1997
Instructor, Clinical Surgery, 1992-1997
Instructor, Clinical Surgery, 1992-1997
Trainees:
Clinical  liver transplant fellows:
Trainee                                  Year/Institution                  Current Position
Dale Rouch, M.D.                   1987/U.Chicago                    Director, Liver Transplant Program
Methodist Hospital, Indiananapolis, IN
James Mayes, M.D.    1987/U.Chicago                    Associate Professor of Surgery, Case
Western University, Cleveland, OH
Steve Woodle, M.D.   1988/U.Chicago                    Professor of Surgery
                                                                                                Univ of Cincinnati
Daniel Cherqui, M.D.1988/U.Chicago                    Director, Liver Transplant Program
Hòpital Henri Mondor Paris, France
Thomas Heffron, M.D.          1989/U.Chicago                    Associate Professor of Surgery;
Emory University, Atlanta, GA
Ginny Bumgardner, 1993/UCSF                            Faculty
M.D., Ph.D.                                                                             Ohio State University, Columbus, OH
Lisa Florence, M.D.    1994/UCSF                            Transplant Surgeon, Swedish Hospital
Seattle, WA
Susan Orloff, M.D.     1993-95/UCSF                                  Faculty
Oregon Health Sciences University
Portland, OR
Michael Wachs, M.D.1993-95/UCSF                      Assistant Professor of Surgery;
University of Colorado
Golden, CO
Chris Freise, M.D.      1994-96/UCSF                                  Professor of Surgery
UCSF
Robert Osorio, M.D.  1995-97/UCSF                      Clinical Professor of Surgery
                                                                                                UCSF
As Program Director:
Larry Stevens, M.D.   1990-91/U.Chicago  Transplant Surgeon, Methodist;
Hospital, Indiananapolis, IN
James Piper, M.D.      1990-91/U.Chicago  Director, Liver Transplant Program
INOVA Maryland
Eric Kortz, M.D.                     1991/U.Chicago                    Transplant & General Surgeon Porter
Memorial Hospital, Denver, CO
Luis Arrazola MD      2000/ Columbia                    Faculty Surgeon
                                                                                                Johns Hopkins 2001-04
Michael Marvin                     2001/Columbia                    Chief Transplantation
                                                                                                Geisinger clinic
John Allendorf                       2003                                       Assistant Prof of Surgery
Columbia 2003-2012
Sarah Bellemare                    2003                                       Assistant Prof of Surgery
                                                                                                Montefiore Medical Center
Raghu Varadarajan   2005                                       Transplant Surgeon India
Anand Khakar                       2005                                       Liver transplant program director
Apollo Hospital,  Chennai, IN
Michael Goldstein      2005                                       Director of Renal Transplantation
                                                                                                University of Miami.  2012-2015.
James Guarrera                     2006                                       Associate Prof of Surgery Columbia U
Benjamin Samstein   2006                                       Associate Prof of Surgery Cornell U
Abrar Khan                2007                                       Transplant Program Director (Emirates)
Rodriguo Sandoval    2007                                       Assistant Prof of Surgery Columbia U
Jason Rolls                              2009                                       Assistant Prof  E. Carolina U
Peter Witkowski                    2009                                       Assistant Prof  U. of Chicago
Shakir Hussein                        2009                                       Advanced fellow in Intestinal
                                                                                                Transplantation U. Pittsburgh
Jang Jeon                                2009                                       Associate Professor of Surgery                                                                                                        Hallym U. Seoul, S. Korea
Thalis Krystophides  2009                                       Registrar Leeds U  UK
Vaughn Whittaker     2010                                       Assistant Clinical Professor,
                                                                                                Roosevelt/St. Lukes NY
Vasilieos Kostaras     2010                                       Transplant fellow NY Medical College
Anthony Watkins      2011                                       Assistant Professor Surg Cornell
Giri Vedula                             2011                                       Transplant Surgeon Florida, Orlando
Madison Cuffy                       2012                                       Assistant Professor  U. of Cinncinati
Arundi Mahendron   2012                                       Assistant Professor London UK
Karim Halazun                       2013                                       Assistant Professor Cornell U NY
Adam Griesemer                   2013                                       Assistant Professor Columbia NY
Soo Yi                          2014                                       Assistant Professor U of Maryland
Christine Du               2014                                       Attending Surgeon Geisinger PA
Ronald Parsons                     2015                                       Assistant Professor Emory GA
Jay Graham                2015                                       Assistant Professor Einstein NY
Tarunjeet Klair                      2016                                       Assistant Professor Univ of Texas SA
Abhishek Mathur      2016                           Attending Surgeon Ochsner clinic
Research Fellow Supervisor:
Trainee                                  Year/Institution                              Current Position
 
Daniel Cherqui,MD               1988/U.Chicago                    Professor of Surgery
Program Hópital Henri Mondor
Paris, France
Andrea Pietrabissa,MD                    1989/U.Chicago                    Staff Surgeon
University of Pisa, Pisa, Italy
Ramesh VeeragandhamMD1990/U.Chicago                    Surgical Resident, UCSD
San Diego, CA
Richang Xia, M.D.                              1990/U.Chicago                    Surgery Resident, Columbia
University, New York, NY
Yuichi Fuku, MD                                1991/U. Chicago                   Asst. Professor of Pediatric
Surgery, Osaka University
Osaka, Jap
Yves Panis,MD                                   1992-93/UCSF                      Surgeon, Assistance Hópitaux
Publique de Paris, Paris, France
Tomonori Nakagawa,MD                 1993-95/UCSF                      Surgical Attending
                                                                                                            Sapporo University Hospital
John Renz, MD                                   1994-97                                 Faculty surgeon Columbia
Takashi Omura, MD              1994-96, UCSF                      Director, Surgical Research
Sapporo University
Guellue Cataldeghirman                  1998-01                                 Surgical Attending: liver
                                                                                                            University of Hamburg
Michael Goldstein                              2000-01                                 Assistant professor, Cornell U.
James Guarrera                                 2001-02                                 Assistant Professor,  Columbia
Niccalesh Iggapunta             2002-03                                 Research fellow
Michael Brubaker                             2009-10                                 Medical Student Univ E Carolina
Jonah Zaretsky                                   2009-2011                            Medical Student Einstein NY
Teaching Columbia P&S:
Associate director of surgical education                 1998- 2000
Medical student clerkship director             1998-2000
Other Professional Activities:
Community Outreach & Public Service:
American Liver Foundation-Medical Advisory Board, 1987-90.
C.L.A.S.S. (Children’s Liver Association Support Services)
Medical Advisory Board, 1996-present
CTDN-Hispanic Media & Professionals-speaker, 1994-present
Coroners’ Clinical Pathologists- Speaker, Merced, CA.
Donor Council (CTDN)-speaker
Operation Kinder-Medical Advisory Board, 1993-present
Ronald McDonald House Advisory Board-San Francisco, CA 1992-present
TRIO member, 1992-present
United Liver Foundation-Medical Advisory Board, 1992-1994
UNOS International Ad Hoc Committee, 1990-1992.
Against All Odds (Cancer Patient Advocacy)  Advisory Board  1999-
TRIO international board member 1999-2001.
Symposium moderator/organizer: Hepatitis C Health effects on the Latino Community     La Salud Hispanica.  May 2001.
 
Professional Committees
     
ASTS: President 2017
ASTS Bylaws Cmte Chair 2009-12
ASTS Councillor 2012-2015
Co-Chair:    Executive Transplant Committee Columbia Presbyterian and New York Cornell 1998-present
Scientific Studies Committee-American Society of Transplant Surgeons,
1993-1995
AASLD Practice Guidelines Committee.   Jan 1998-1999.
UNOS liver subcommittee, Region 9 representative 1999-2001
Committee on Organ Procurement Chair:
American Society of Transplant Surgeons,  2000-03.
New York Organ Donor Network  Vice-chair Medical Board 2001-
AASLD Liver transplantation and Hepatology Committee 2002-
UNOS region 9 associate councilor/Councilor elect 2004-06.
New York Organ Donor Network  Vice-chair Medical Board 2001-
UNOS Membership and professional standards 2004-06.
New York Organ Donor Network  Vice Chair 2007-2009.
Chair Governance Committee 2005-7
American Surgical Association: Membership committee 2006-09.
UNOS Councillor Region 9 2006-2008.
UNOS Board of Directors 2006-2008
UNOS Board of Directors, Nominations Committee 2006
New York Organ Donor Network  Vice Chair 2008-2012.
ASTS Bylaws Cmte Chair 2009-12
ASTS Councillor 2012-2015
ILTS Publications committee 2015-
AASLD SIG Liver Transplantation Chair 2014-2017
Deputy Editor:
Transplantation July 2015-
Journal Editorial Boards
Advances in Gastroenterology, Hepatology & Clinical Nutrition-Section Editor 1995-1997.
Clinical Transplantation-Section Editor, 1996-present
World J. of Surgery Editorial Board 1998-2010
Contemporary Surgery 1999-
Liver Transplantation 1999-
Transplantation 2001-2015
Journal Review (Ad Hoc)
Annals of Surgery
Gastroenterology, 1988-present
Hepatology, 1989-present
Cambridge Quarterly of Medical Ethics 1996-present
JAMA, 1988-present
Journal of the American College of Surgeons
Journal of Pediatric Gastroenterology and Nutrition, 1990-present
Journal of Surgical Research, 1987-present
Liver Transplantation and Surgery, 1993-present
Surgery
Transplantation, 1990-present
Archives of Surgery, 1995-present
American Journal of Transplantation 2001-present
 
Bibliography
 
Original Peer Reviewed Articles:
 
 
  1. Gugenheim J, Houssin D, Emond JC, Gigou M, Crougneau S, Bismuth H Delayed rejection of heart allografts in hypersensitized rats by extracorporeal donor-specific liver hemoperfusion.Transplantation 1986; 41:398.
  2. Castaing D, Emond JC, Kunstlinger F, Bismuth H. Utility of operative ultrasound in the surgical management of liver tumors. Ann Surg 1986; 204:600-605.
  3. Houssin D, Bellon B, Brunaud M, Gugenheim J, Settaf A, Meriggi F, Emond JC. Interactions between liver allografts and lyphocytotoxic alloantibodies in inbred rats.Hepatology 1986; 6:994.
  4. Meriggi F, Marchetti C, Poggi P, Marsetti M, Leidi GL, Emond JC, Houssin D.
Forni E. Gastric smooth muscle cell electron microscopic aspects according: PGE contents after truncal vagotomy or portal stenosis in the rat.  Giorn Chir
1986; 7: 1447-1450.
  1. Baudot P, Capron-Laudereau M, Emond JC, Gane P, Rouger P, Houssin D. Early disappearance of donor-specific immunofluorescence in spontaneously tolerated liver allografts in inbred rats.  Transplant Proc 1987; 19: 200-204.
  2. *Ferrari M, Emond JC, Thistlethwaite JR, Carmellini M, Broelsch C. L’esperienza dei trapianti epatici all’ universita di Chicago. Estratto da Minerva Chirurgica 1987;42 (17):1277-1285.
  3. *Emond JC, Thistlethwaite JR, Baker A, Whitington P, Ferrari M. Carmellini M, Stuart F, Broelsch C.Rejection in liver allograft recipients: Clinical characterization and management.  Clin Trans 1987;1:143-150.
  4. Broelsch C. Then P, Thistlethwaite JR, Emond JC. Heterotoper oder orthotoper
leberersatz durch lebersegmente? Ergeb. der Gastroenterologie (Verh Bd 1986) 1987; 22:66-72.
  1. Then P, Emond JC, Lygidakis N, Broelsch C: Hemodynamic evaluation of orthotopically transplanted hepatic segments. Langenbeck’s Archiv, Chirurg.
Forum, 1987; Springer Verlag: 259-265.
  • *Emond JC, Capron-Laudereau M, Meriggi F, Reynes M, Houssin D. Acute liver failure after subtotal hepatectomy in the rat: Failure of testosterone pretreatment and hepatocyte transplantation to improve survival.  Current Surg 1988; 45: 200-203.
  • Broelsch CE, Emond JC, Thistlethwaite JR, Rouch DA, Whitington PF, Lichtor JL. Liver transplantation with reduced-size donor organs. Transplantation 1988;45; 519-523.
  • Lichtor JL, Emond JC Chung, MR, Thistlethwaite JR, Broelsch CE. Pediatric orthoptic liver transplantation: multifactorial predictions of blood loss.Anesthesiology, 1988 Apr, 68(4): 607-11.
  • Thistlethwaite JR, Jr, GaberAO, Stuart FP, Lloyd DM, Emond JC, Rouch Broelsch CE. Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts for transplantation.  Transplant Proc 1988; 20:833-834.
  • Broelsch CE, Emond JC, Thistlethwaite JR, Whitington PF, Zuker A. Baker AL, Aran Pf, Rouch DA, Lichtor JL.Liver Transplantation, including the concept of reduced-sized liver transplants in children. Ann Surg 1988; 208 (4): 410-420.
  • Rouch DA, Thistlethwaite JR, Lichtor L, Emond JC, Broelsch CE: Effect massive transfusion during liver transplantation on rejection and infection. Transplant Proc 1988; 20: 1135-1137.
  • Broelsch CE, Emond JC, Dippe B. GroBenreduktion der spenderleber vor orthotoper transplantation. Operationstechnik and Ergebnisse. Der Chirurg 1988; 59: 558-564.
  • Gaber AO, Thistlethwaite JR, Busse-Henry S, Aboushloe M, Emond JC, Rouch D, Broelsch CE. Improved results of preservation of hepatic grafts preflushed with albumin and protaglandins. Transplant Proc 1988; 20: 992-993.
  • Pietrabissa , Cherqui D, Emond JC, Roncella M, Brown SB, Broelsch CE. LaDoppler Flowmetry to Monitor Hepatic Blood Flow. Proceedings of World Association of Hepato-Pancreato-Biliary Surgery.Gozzetti G; Esserre EdizioniBologna 1988; 525-528.
  • Ellis J, Lichtor JL, Feinstein S, Chung M, Polk S, Broelsch C, Emond JC, Thistlethwaite Jr, Roizen M. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation: A transesophageal dimensional echocardiographic study. Anesthesiology & Analgesia 1989; 68:777-782.
  • *Emond JC, Mayes JT, Rouch DA, Thistlethwaite JR, Broelsch CE. Experience with radical resection in the management of proximal bile duct cancer.HPB Surg1989; 1 (4): 297-307.
  • *Emond JC, Whitington PF, Thistlethwaite JR, Alonso EM, Broelsch CE. reduced–size liver orthotopic liver transplantation in children: Use in the management of children with chronic liver disease. Hepatology 1989; 10: 867-872.
  • *Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker A. Liver transplantation in the management of fulminant hepatic failure.Gastroenterology 1989; 96:1583-1588.
  • Vogelbach P, Emond JC, Thistlethwaite JR,Woodle S, Busse-Henry S, Broelsch CE. Die Praservierung von Spenderlebern mit UW-Losung Erste Erfahrungen an der University of Chicago. Chirurgisches Forum 1989; 435-439.
  • *Emond JC, Capron-Laudereau M, Meriggi F, Bernauau J, Reynes M, and Houssin D, Extent of hepatectomy in the rat: Evaluation of basal conditions and effect of therapy. Euro Surg Res 1989; 21: 251-259.
  • Singer PA, Siegler M, Lantos JD, Emond JC, Whitington PF, Thistlethwaite JR, Broelsch CE: Ethics of liver transplantation with living donors. NEJM 1989;321:620-621.
  • Broelsch CE, Vogelbach P, Emond JC, Thistlethwaite Jr, Woodle SA,, Baker AL, Whitington PF. Shuntchirurgie im hinblick auf die indikation zur lebertransplantation. [Shunt surgery with reference to indications for liver transplantation]. Langenbecks Archiv fur Chirurgie.  Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie, 1989:293-9.
  • Broelsch CE, Emond J; Dippe B.[Size reduction of the donor liver before orthotopic transplantation. Surgical technic and results]. Chirurg, 1988 Aug, 59 (8): 558-64.
  • Meriggi F, Forni E, Houssin D, Emond JC, Morone C: Il problema del trapianto di fegato nel paziente HBs Ag positivo. Minerva Medica 1989; 80: 769-770.
  • Whitington PF, Emond JC, Whitington SH, Broelsch CE, Baker A: Small-bowel length and the dose of cyclosporine in children after liver transplantation. NEJM 1990; 322 (11): 733.
  • Singer PA, Siegler M, Lantos JD, Emond JC, Whitington PF, Thistlethwaite JR, Broelsch CE. The ethical assessment of innovative therapies: Liver transplantation using living donors. Theoretical Med 1990; 11: 87-94.
  • Rouch DA, Emond JC, Thistlethwaite JR, Mayes JT, Broelsch CE. Choledochostomy without a T-tube or internal stent in liver transplantation. Surg Gynecol & Obstet 1990; 170: 239-244.
  • Woodle ES, Thistlethwaite JR, Emond JC, Whitington PF, Yousefzadeh DK, Broelsch CE. Successful orthotopic liver transplantation in congenital absence of the portal vein. Surgery 1990; 107:475-9.
  • Broelsch CE, Whitington PF, Emond JC. Evolution and future perspectives for reduced-size liver transplantation. Surg Gynecol Obstet 1990; 171: 353-60.
  • Cherqui D, Emond JC, Pietrabissa A, Michael M, Roncella M, Brown S, Whitington PF, Broelsch CE. Segmental liver transplantation from living donors:Report of the technique and preliminary results in dogs.  Hpb Surgery 1990 Jul, 2 (3): 189-202.
  • Thistlethwaite JR, Emond JC.Woodle ES, Vogelbach P, Black D, Whitington PF , Broelsch CE. Increased utilization of organ donors:  Transplantation of two recipients from single donor livers.  Transplant Proc 1990; 22 (4): 1485-1486.
  • *Emond JC, Whitington PF, Thistlethwaite JR, CherquiD, Alonso EA, Woodle ES, Vogelbach P, Busse-Henry SM, Zucker AR, Broelsch CE.Transplantation of two patients with one liver: Analysis of a preliminary experience with “Split Liver” grafting.  Ann Surg 1990; 212 (1): 14-22.
  • Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor L. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990; 212 (3): 368-377.
  • Samsel RW, Cherqui D, Pietrabissa A, Sanders WM, Roncella M, Emond JC, Schumacker PT. Hepatic oxygen and lactate extraction during stagnant hypoxia.J App Physiol 1991; 70 (1): 186-193.
  • George DL, Arnow PM, Fox A, Baker AL, Thistlethwaite JR, Emond JC, Whitington PF, Broelsch CE. Bacterial infection as a complication of livertransplantation:  Epidemiology and risk factors.  Rev Inf Dis 1991; 13: 387-396.
  1. Woodle ES, Budzinski J, Pitman M, Flanagan L, Boone P, Smith C, Whitington PF, Emond JC, Broelsch CE. Reduced-size liver transplantation. Hope for pediatric patient with end-stage liver disease.  Aorn Journal , 1990 Aug, 52 (2): 252-60.
  2. Koneru B, Flye MW, Busuttil RW, Shaw BW, Lorber MI, Emond JC, Kalayoglu M, Freese DK, Starzl TE. Liver Transplantation for hepatoblastoma- The American Experience.  An Surg 1991; 213  (2): 118-121.
44.Stevens L, Piper J, Emond JC, Heffron T, Baker A, Broelsch C.  Liver transplantation for controversial indications:   Alcoholic liver disease, hepatic cancers, and viral hepatitis.  Transplant Proc. 1991, 23 (3): 1915-1916.
  1. Woodle ES, Thistlethwaite JR, Emond JC, Whitington PF, Black DD, Aran PP, Baker AL, Stuart FP, Broelsch CE. OKT3 for hepatic allograft rejection:  Differential response in adults and children.  Transplantation 1991; 51 (6):1207-1212.
  2. Broelsch CE, Whitington PF, Emond JC, Heffron TG, Thistlethwaite JR, Stevens L, Piper J, Whitington SH, Lichtor JL. Liver transplantation in children from living related donors:  Surgical techniques and results.  An Surg 1991; 214(4): 428-439.
  3. Cherqui D, Emond JC, Pietrabissa A, Michel M, Roncella M, Broelsch CE.Transplantation hepatique orthotopique et donneur vivant:  Etude experimentale chez le chien.  [Orthotopic liver transplantation and living donors.  An experimental study in the dog].  Chirurgie 1990, 116 (8-9): 711-20.
  4. Thistlethwaite JR, Emond JC, Heffron TG, Whitington PF, Black DD, Broelsch CE. Innovative use of organs for liver transplantation.  Transplant Proc 1991;23 (4): 3047-3051.
  5. Vogelbach P, Emond JC, Thistlethwaite JR, Broelsch CE.Splitting Lebertransplantation. [Splitting liver    Orthotopic liver transplantation in two recipients with a single donor liver ]. Helvetica Chirurgica Acta, 1991 Jul, 58 (1-2): 147-8.
  6. Vogelbach P, Emond JC, Thistlethwaite JR, Broelsch CE. Die Konservierung von Spenderlebern mit University of Wisconsin-Losung. [ Preservation of donor livers with University of Wisconsin solution]. Helvetica Chirurgica Acta, 1991 Jul, 58 (1-2): 159-61.
  7. *Stevens LH, Emond JC, Piper JB, Heffron TG, Thistlethwaite JR, Whitington PF, Broelsch CE.  Hepatic artery thrombosis in infants:  A comparison of whole livers, reduced-size grafts, and grafts from living related donors.  Transplantation 1992;  53 (2): 396-399.
  8. *Heffron TG, Emond JC, Whitington PF, Thistlethwaite JR, Stevens L, Piper J, Whitington S, Broelsch C. Biliary complications in pediatric liver transplantation:  Comparison of reduced size and whole grafts. Transplantation1992; 53(2): 391-395.
  9. Lloyd DM, Pieper F, Gundlach M, Knoefel WT, Burdelski M, Biermann CW, Emond JC, Heffron TG, Whitington PF, Broelsch CE.  Developments in segmental and living related liver transplantation. Transplant Proc 1992; 24: 1287-92.
  10. Whitington PF, Freese DK, Alonso EM, Fishbein MH, Emond JC. Progressive familial intrahepatic cholestasis (Byler’s disease).  In: Falk symposium 63 Pediatric Cholestasis: Novel Approaches to Treatment. Ed: Lentz M and Reichen J.  Kluwer Academic Publishers, Dordrecht, Boston, London. 1992: 165-180.
  11. George DL, Arnow PM, Fox A, Thistlethwaite JR, Emond JC, Broelsch CE, Whitington PF. Patterns of infection after pediatric liver transplantation.  American Journal of Diseases of Children 1992 Aug, 146 (8): 924-9.
  12. *Emond JC, Heffron TG, Whitington PF, Broelsch CE. Reconstruction of the hepatic vein in reduced size hepatic transplantation.  Surg, Gyn & Obstet 1993; 76: 11-17.
  13. *Emond JC, Heffron  Short term results of living related liver transplantation Japanese J Ped Surg 1993; 29 (1): 53-57.
  14. *Emond JC, Heffron TG. Surgical problems in pediatric liver transplantation.Japanese J of Ped Surg 1993; 29 (2): 243-251.
  15. *Contis JC, Kortz E, Heffron TG, Whitington PF, Emond JC. The use of an absorbable suture material in the vascular anastomoses in pediatric liver    Trans Proc 1993; 25 (2): 1878-80.
  16. *Emond JC, Heffron TG, Kortz EO, Gonzalez-Vallina R, Contis JC, Black DD,Whitington PF. Improved results of living related liver transplantation (LRT) with routine application in a pediatric program.  Transplantation 1993; 55 (4): 835-40.
  17. *Ben-Ami T, Martich V, Yousefzadeh D, Whitington P, Emond JC.Anatomic features of reduced size liver transplantation: Postsurgical imaging characteristics.  Radiology 1993; 187: 165-70.
  18. *Heffron TG, Kortz EO, Contis JC, Watkins PA, Davis B, Jasionsowski T, Thistlethwaite JR, Emond JC. Use of cryopreserved vein allogenic homografts in liver transplantation. Trans Proc 1993; 25: 1091-92.
  19. *Xia R, Emond JC. Orthotopic partial liver transplantation in the rat:  A model of 70% hepatectomy and reduced size liver transplantation . Transplantation 1993; 56 (4): 1041-43.
  20. *Veeragandham RS, Brown SB, Xia R, Emond JC. Improved technique of 70% hepatectomy in dogs.  Eur Surg Res 1993; 16 (2).
  21. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure.  Arch Surg 1993; 128: 677-82.
  22. Ho KS, Lashner BA, Emond JC, Baker AL, Prior esophageal variceal bleeding does not adversely affect survival following orthotopic liver transplantation.  Hepatology 1993; 18 (1): 66-72.
  23. Ascher NL, Lake JR, Emond JC, Robert JR. Liver transplantation for viral C related cirrhosis.
  24. Whitington PF, Emond JC, Heffron T, Thistlethwaite JR. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1.   Lancet 1993: 342:779-80.
  25. *Emond JC; Nelson RM; Blank EL; Shapiro RS; MacKay C. Living related liver transplantation:  request for an international ethics consultation from the Research Center for Surgery in Moscow.  Cambridge Quarterly of Healthcare Ethics 1994 Fall, 3 94): 602-3.
  26. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond JC, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincente F, Stock P. The risk of transmission of hepatitis B from HbsAg(-), HbcASb(+), HBIgM(-)organ donors. Transplantation 1995; 59(2): 230-34.
  27. Aboulijoud MS, Levy MF, Klintmalm GB, et al. Hyperlipidemia after liver transplantation: Long-term results of the FK506/cyclosporine a US multicenter trial.  Trans Proc 1995; 27 (1): 1121-23.
  28. *Renz JF, Mudge CL, Heyman MB, Tomlanovich S, Kingsford RP, Moore BJ, Snyder JD, Perr HA, Paschal Al, Roberts JP, Ascher NL, Emond JC. Donor selection limits use of living-related liver transplantation. Hepatology 1995; 22 (4)  1122-6.
  29. Busutill R, McDiarmid S, Klintmalm G, Goldstein R, Miller C, Schwartz M, Shaw B, Roberts J, Hebert M, Esquivel C, Nakazato P, Wiesner R, Krom R, Kalayoglu M, D’Alessandro A,  Marsh J, Peters, Burdick J, Klein A, Lewis W, Jenkins R, Thistlethwaite J, Emond JC, Jusko W. (U.S. Multicenter FK506 Liver Study Group).  Comparison of FK506 and cyclosporine for immunosuppression in liver transplantation. NEJM 1994; 331: 1110-1115.
  30. *Emond JC, Wachs, ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim Jr. RC. Total vascular exclusion (TVE) for major hepatectomy in patients with abnormal liver parenchyma.  Arch Surg 1995; 130: 824-31.
  31. Narumi S, Roberts JP, Emond JC, Lake JR, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22 (2): 451-57.
  32. *Emond JC, Whitington PF. Selective surgical management of progressive familial intrahepatic cholestasis (Byler’s disease).  J of Pediatric Surg 1995; 30 (12): 1635-41.
  33. Venook AP, Ferrell LD, Roberts JP, Emond JC, Frye JW, Ring, E, Ascher, NL Lake JR. “Liver Transplantation for Hepatocellular Carcinoma: Results with preoperative  Liver Transplantation and Surgery Vol.1 No.4  (July) 1995; pp 242-248.
  34. *Emond JC, Polastri R. Anatomical hepatectomy for resection or transplantation.Amer J of Surgery 1996; 172: 29-34.
  35. *Emond JC, Kelley S, Heffron T, Nakagawa T, Roberts JP, Lim RC. Surgical and anesthetic management of patients undergoing major hepatectomy with total vascular isolation.  Liver Transplantation & Surgery 1996; 2 (2): 91-8.
  36. *Emond JC, Stock P, Roberts JP, Ascher NL. Strategies for tolerance induction: Potential applications in living donor liver transplantation.  Transplantation Proceedings, 1996 Aug, 28 (4): 2371-4.
  37. *Emond JC, Rosenthal P, Roberts JP, Stock P, Kelley S, Gregory G, Lim RC, Ascher NL. Living related liver transplantation:  The UCSF experience.  Transplantation Proceedings, 1996 Aug, 28 (4): 2375-7.
  38. Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC, Ascher NL, Roberts JP.The use of the T-tube following orthotopic liver transplantation.  Transplantation 1996; 61 (2): 258-61.
  39. Brown RS, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP.Incidence and significance of aspergillus cultures following liver and kidney transplantation.  Transplantation, 1996 Jul 27, 62 (2): 292-3.
  40. *Omura T, Ascher NL, Emond JC. Fifty percent partial liver transplantation in the rat.. Transplantation,  1996 Jul 27 62(2): 292-3.
  41. *Emond JC, Renz JF, Lim RC, Roberts JP, Ascher NL. Functional characterization of liver grafts from living donors: implications for the treatment of older children and adults.  Ann Surg 1996; 224 (4): 544-52.
  42. Kuang A, Renz JF, Rosenthal P, Roberts JP, Lim R, Ascher NL, Emond JC. Decreased mortality from technical failure leads to improved results of pediatric liver transplantation. Arch Surg. 1996; 131, 887-93.
  43. *Emond JC, Leib M. The living-related liver transplant evaluation:  Linking risk factors and outcome.  Liver Transplantation and Surgery (In press).
  44. *Kuang AA, Renz JF, Ferrell LD, Ring EJ, Rosenthal P, Lim RC, Roberts JP,Ascher NL, Emond JC. Failure patterns of cryopreserved vein grafts in liver transplantation.   Transplantation 1996; 62 (6): 742-47.
  45. *Panis Y, McMullan DM, Emond JC. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after major resection.  Surgery 1997; 1121 (2): 142-9.
  46. Brown Jr RS, Ascher NL, Lake JR, Emond JC, Bacchetti P, Randall HB, Robert JP. The impact of surgical complications after liver transplantation on resource utilization. Arch Surg 1997; 132: 1098-1103.
  47. *Takashi O, Tomonori N, Randall HB, Zhonghua L, Huey M, Ascher NL, EmondJC. “ Increased Immune Responses to Regenerating Partial Liver Grafts in the Rat”. J Surg Research 70, 34-40, 1997)
  48. *Renz JF, Rosenthal P, Roberts JP, Ascher NL, Emond JC. Planned Exploration of Pediatric Liver Transplant Recipients Reduces Posttransplant Morbidity and Lowers Length of Hospitalization. Arch Surg 1997; 132: 950-956.
  49. *Rosenthal P, Roberts J, Ascher NL, Emond JC. Auxiliary liver transplant in fulminant failure.   Pediatrics  1997  100:e10.
  50. Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher NL, Ferrrell L.Pathological Changes in Yearly Protocol Liver Biopsy Specimens From Healthy Pediatric Liver Recipients. Liver Transplantation and Surgery, Vol.3 No.6 (November), 1997:pp 559-562.
  51. *Reichert PR, Renz JF, Bacchetti P, Lim RC, Roberts JP, Ascher NL, Emond JC. Biliary Complications of Reduced-Organ Liver Transplantation Liver Transplantation and Surgery 1998, 4:343-349.
  52. *Renz JF, de Roos M, Rosenthal P, Bacchetti P, Watson J, Stock P, Roberts JP, Hyman M, Ascher NL, Emond JC. Post-Transplantation Growth In Pediatric Liver Recipients.  Liver transplantation  (In press).
  53. *Panis Y, Lomri, N, Emond JC. Early gene expression associated with regeneration is intact after massive hepatectomy in rats.   Surg. Res. 1998, 79:103-108.
  54. Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, Linna TJ, Roberts JP. Four-year follow-up of mycophenolate mofetil for graft rescue in liver
allograft recipients. Transplantation 1999 Mar 15;67(5):707-12.
  1. Renz JF, Lightdale J, Mudge C, Bacchetti P, Watson J, Ascher NL, Emond JC, Rosenthal P, Roberts JP. Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients. Liver Transpl Surg 1999 Mar;5(2):136-43.
  2. Lattyak BV, Rosenthal P, Mudge C, Roberts JP, Renze JF, Osorio RW, Emond JC, Lalwani AK . Posttransplant lymphoproliferative disorder presenting in the head and neck. Laryngoscope 1998 Aug;108(8 Pt 1):1195-8 .
  3. Brown RS Jr, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Liver Transpl Surg 1998 Mar;4(2):170-6.
  4. Whitington PF, Alonso EM, Boyle JT, Molleston JP, Rosenthal P, Emond JC, Millis JM Liver transplantation for the treatment of urea cycle disorders.  J Inherit Metab Dis 1998;21 Suppl 1:112-8.
  5. Matern D, Starzl TE, Arnauot W, Barnard J, Bynon JS, Dhawan A, Emond JC, Haagsma EB, Hug G, Lachaux A, Smit GPA, Chen YT.  Liver transplantation for glycogen storage disease types I, III, and IV.  Eur J Pediatr (1999),   158[suppl 2]: S43-S48.
  6. Reichart PR, Renz JF, D’Albuquerque LA, Rosenthal P,  Lim RC, , Roberts JP,  Ascher NL,  Emond JC. Surgical anatomy of the left lateral segment as applied to living donor and split liver transplantation: A clinico-pathologic study Ann Surg 2000 Nov;232(5):658-64.
  7. Renz JF, Reichert PR, Emond JC. Hepatic arterial anatomy as applied to living-donor and split-liver transplantation. Liver Transpl 2000 May;6(3):367-9.
  8. Dower NA, Smith LJ, Lees G, Kneteman N, Idikio H, Emond J, Rosenthal P. Experience with aggressive therapy in three children with unresectable malignant liver tumors. Med Pediatr Oncol. 2000 Feb;34(2):132-5.
  9. Emond JC, De Luca T.  Il trapianto di fegato da familiare vivente: selezione di riciventi e donatori Minerva Chir 2000 Nov;55(11):759-69
  10. Renz JF, Reichert PR, Emond JC. Biliary anatomy as applied to pediatric living donor and split-liver transplantation.   Liver Transpl 2000 Nov;6(6):801-4.
  11. Robert S. Brown, Jr., K. Shiva Kumar, Steven J. Lobritto, Dianne L. Rudow, Patricia Harren, Milan Kinkhabwala, Sandip Kapur, Jean C. Emond. Comparison of May end-stage liver disease (MELD) scores and Child-Turcotte-Pugh (CPT) scores as predictors of pre liver transplant (LT) disease severityand post-LT outcomes in UNOS status 2A patients. Liver Transpl. 2002 Mar;8(3):278-84.
  12. Diaz GC, Renz JF, Mudge C, Roberts JP, Ascher NL, Emond JC, Rosenthal P. Donor health assessment following living-donor transplantation.Ann Surg 236(1):120-126, 2002.
  13. Renz JF, DeRoos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, Roberts JP,  Ascher NL, Emond JC.    Post-transplantation growth in pediatric liver recipients. Liver Transpl 2001 Dec;7(12):1040-55
  14. Salame E, Soauf R, Kinkhabwala M, Harren P, Finn R, Brown RS, Emond JC.Impact of the extent of hepatectomy on donor outcomes:liver function and clinical recovery after living donor liver transplantation. Am J Transplant. 2002 Sep;2(8):780-8.
  15. Emond JC, Freeman RB, RenzJF, Rogiers X, Busuttil RW. Optimizing the use of donated cadaver livers:  Analysis and policy development to increase the use of split livers.   Liver Transpl. 2002 Oct;8(10):863-72.
  16. Goldstein MJ, Kapur S, Kinkhabwala M, Harren P, LaPoint-Rudow D, Lobritto SJ, Russo M, Brown RS, Weinberg A, Renz JF, Emond JC. Analysis of failure in living donor liver transplants: Differential outcomes in adults and children. World J Surg. 2003 Mar;27(3):356-64.
  17. Bruce R. Rosengard,. Sandy Feng,. Edward J. Alfrey, Jon Zaroff, Jean C. Emond, Mitchell L. Henry,. Edward R. Garrity, John P. Roberts, James J. Wynn, Robert A. Metzger, Richard B. Freeman, Friedrich K. Port, Robert B. Love, Ronald W. Busuttil, Francis L. Delmonico. Report of the Crystal City Meeting To Maximize the Use of Organs Recovered from the Cadaver Donor AmJ Transplantation 2002 Sep;2(8):701-11
  18. Rudow DL, Russo MW, Hafliger S, Emond JC, Brown RS Jr.Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donors.Liver Transpl 2003 Mar;9(3):254-9
  19. *Kinkhabwala MM, Guarrera JV, Leno R, Brown RS, Prowda J, Kapur S, Emond JC.Outflow reconstruction in right hepatic live donor liver transplantation. Surgery 2003 Mar;133(3):243-50
  20. Paul J. Gaglio, 1Srikar Malireddy, 1Brian S. Levitt, , 2Dianne Lapointe-Rudow, , 3Jay Lefkowitch, 4Milan Kinkhabwala,1Mark W. Russo, 4Jean C Emond, and 1Robert S. Brown, Jr. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors.  Liver Transpl. 2003 Oct;9(10):1028-35.
  21. Mark W. Russo, Dianne LaPointe-Rudow, Milan Kinkhabwala, Jean C Emond, Robert S. Brown. Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transplantation 2004 Mar;4(3):427-31
  22. *Shan Zeng1, Nikki Feirt2, Michael Goldstein1, James Guarrera1, Udeme Ekong3, Yan Lu4, Wu Qu4, Ann Marie Schmidt4and Jean C. Emond. Blockade of the receptor for AGE (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 2004 39:422-432.
  23. *Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Split liver transplantation in the United States: Outcomes of a national survey. Ann Surg. 2004 Feb;239(2):172-81
  24. Akinlolu O. Ojo, Dennis Heinrichs, Jean C. Emond, Joshua J. McGowan, Mary K. Guidinger, Francis L. Delmonico, Robert A. Metzger.  Organ Donation and Utilization in the United States   AmJ Transplantation 2004 4(Supp 9):27-37.
  25. Russo MW, Lapointe-Rudow D, Teixeira A, Guarrera J, Dove LD, Gaglio P, Emond JC, Kinkhabwala M, Brown RS. Interpretation of Liver Chemistries in Adult Donors After Living Donor Liver Transplantation. J Clin Gastroenterol. 2004 Oct;38(9):810-4.
  26. Guarrera JV, Sinha P, Lobritto SJ, Brown RS Jr, Kinkhabwala M, Emond JC. Microvascular hepatic artery anastomosis in pediatric segmental liver transplantation: microscope vs loupe. Transpl Int. 2004 Nov;17(10):585-8. Epub 2004 Nov 3.
  27. Rudow DL, Brown RS Jr, Emond JC, Marratta D, Bellemare S, Kinkhabwala M. One-year morbidity after donor right hepatectomy.Liver Transpl. 2004 Nov;10(11):1428-31.
  28. Emond JC, Samstein B, Renz JF. A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes. World J Surg. 2005 Feb;29(2):124-30 .
  29. Cataldegirmen G, Zang S, Feirt N, Qu W, Lu Y, Hofmann MA, Pachydaki S, Wendt T, Baghat G, Weinberg A, Lefkowitch J, Rogiers X, Yan SF, Schmidt AM and Emond RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB.    J Exp Med. 2005 Feb 7;201(3):473-84.
  30. Yao FY, Kinkhabwala M, LaBerge J, Bass NM, Brown RS, Jr., Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.Am J Transplant. 2005 Apr;5(4 Pt 1):795-804.
  31. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise, CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC; A2ALL Study Group. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005 Sep;242(3):314-23.
  32. Renz JF, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M, Brown R Jr, Emond JC. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation.  Ann Surg. 2005 Oct;242(4):556-63;
  33. Moss J, Lapointe-Rudow D, Renz JF, Kinkhabwala M, Dove LM, Gaglio PJ, Emond JC, Brown RS Jr. Select utilization of obese donors in living donor liver transplantation:implications for the donor pool. Am J Transplant. 2005 Dec;5(12):2974-81.
  34. Verna EC, Hunt KH, Renz JF, Rudow DL, Hafliger S, Dove LM, Kinkhabwala M, Emond JC, Brown RS Jr. Predictors of candidate maturation among potential living donors. Am J Transplant. 2005 Oct;5(10):2549-54.
  35. Alkofer B, Samstein B, Guarrera JV, Kin C, Jan D, Bellemare S, Kinkhabwala M, Brown R Jr, Emond JC, Renz JF. Extended-donor criteria liver allografts.  Semin Liver Dis. 2006 Aug;26(3):221-33.
  36. Ekong U, Zeng S, Dun H, Feirt N, Guo J, Ippagunta N, Guarrera JV, Lu Y, Weinberg A, Qu W, Ramasamy R, Schmidt AM, Emond JC. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J Gastroenterol Hepatol. 2006 Apr;21(4):682-8.
  37. Lefkowitch JH, Lobritto SJ, Brown RS Jr, Emond JC, Schilsky ML, Rosenthal LA, George DM, Cairo MS. Ground-glass, polyglucosan-like hepatocellular inclusions: A “new” diagnostic entity. 2006 Sep;131(3):713-8.
  38. Ventura K, Rekhtman Y, Jan D, Emond J, Lobritto S. Isolated liver transplantation for decompensated end-stage liver disease in children with intestinal failure. Transplant Proc. 2006 Jul-Aug;38(6):1699-701.
  39. Vakiani E, Hunt KK, Mazziotta RM, Emond JC, Brown RS, Lefkowitch JH, Bhagat G.Hepatitis C-associated granulomas after liver transplantation: morphologic spectrum and clinical implications. Am J Clin Pathol. 2007 Jan;127(1):128-34.
  40. Herold K, Moser B, Chen Y, Zeng S, Yan SF, Ramasamy R, Emond J, Clynes R,Schmidt AM.   Receptor for advanced glycation end products (RAGE) in a dash to the rescue:  inflammatory signals gone awry in the primal response to stress.  J Leukoc Biol. 2007 Aug;82(2):204-12. Epub 2007 May 18.
  41. Diaz GC, Renz JF, Nishanian E, Kinkhabwala M, Emond JC, Wagener G. Anesthetic management of combined heart-liver transplantation.J Cardiothorac Vasc Anesth. 2007 Apr;21(2):253-6.
  42. Brown R Jr, Emond JC. Managing access to liver transplantation: implications for gastroenterology practice.   2007 Mar;132(3):1152-63.
  43. Egorova NN, Moskowitz A, Gelijns A, Weinberg A, Curty J, Rabin-Fastman B,
Kaplan H, Cooper M, Fowler D, Emond JC, Greco G. Managing the prevention of retained surgical instruments: what is the value of counting?
Ann Surg. 2008 Jan;247(1):13-8.
  1. Siegel AB, McBride RB, El-Serag HB, Hershman DL, Brown RS Jr, Renz JF, Emond J, Neugut AI. Racial Disparities in Utilization of Liver Transplantation Gastroenterology. 2008 Aug;135(2):468-76. Epub 2008 Apr 22. for Hepatocellular Carcinoma in the United States, 1998-2002.Am J Gastroenterol. 2007 Nov 15;
  2. Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, SaabS,Wisniewski KA, Trotter JF; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study.   Liver Transpl. 2008 Sep;14(9):1273-80.
  3. Bulman W, Coyle CM, Brentjens TE, Horn EM, Dickstein ML, Wilt JS, Emond J, Kawut SM. Severe pulmonary hypertension due to chronic echinococcal pulmonary emboli treated with targeted pulmonary vascular therapy and hepatic resection. Chest 2007 Oct;132(4):1356-8.
  4. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, EmondJC, Koffron AJ, Pruett TL, Olthoff KM; A2ALL Study Group.  Donor morbidity after living donation for liver transplantation.   2008 Aug;135(2):468-76. Epub 2008 Apr 22
  5. Guarrera JV, Alkofer BJ, Feirt N, Sandoval R, Samstein B, Smith ET Jr,
Marshman D, Cogswell C, Vannatta J, Brown RS Jr, Emond JC, Renz JF. Discovery of diffuse biliary microhamartomas during liver procurement.   Liver Transpl. 2007 Oct;13(10):1470-1.
  1. Halazun KJ, Hardy MA, Rana AA, Woodland DC 4th, Luyten EJ, Mahadev S,
Witkowski P, Siegel AB, Brown RS Jr, Emond JC. Negative impact of
neutrophil-lymphocyte ratio on outcome after liver transplantation for
hepatocellular carcinoma. Ann Surg. 2009 Jul;250(1):141-51. PubMed PMID:
19561458.
  1. Gebhard Wagener, MD1#,Gina Gubitosa, BA1,John Renz, MD, PhD2,Milan Kinkhabwala, MD2,Tricia Brentjens, MD1,James V. Guarrera, MD2,Robert Brown, MD, MPH3,Donald Landry, MD PhD3,Jean Emond, MD2Vasopressin decreases portal vein pressure and flow during orthotopic liver transplantation Liver Transpl. 2008 Nov;14(11):1664-70.
  2. Lai, JC, Pichardo, EM, Emond JC, Brown RS Jr. Resource Utilization of Living Donor Versus Deceased Donor Liver Transplantation is Similar at an Experienced Transplant Center. Am Jour of Trans 2009; 8: 1-5 (in press).
  3. Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault NA; the A2ALL Study Group. Incidence and Severity of Acute Cellular Rejection in Recipients Undergoing Adult Living Donor or Deceased Donor Liver Transplantation. Am J Transplant. 2008 Dec 15.
  4. Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE; A2ALL Study Group. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008 Dec;8(12):2569-79.
  5. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Guarrera JV, Brown RS Jr, Emond JC. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008 Dec;8(12):2537-46. Epub 2008 Sep 25
  6. Cowles RA, Lobritto SJ, Ventura KA, Harren PA, Gelbard R, Emond JC, Altman RP,  Jan DM.  Timing of liver transplantation in biliary atresia-results in 71 children managed by a multidisciplinary team.  J Pediatr Surg. 2008
Sep;43(9):1605-9.
  1. Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl. 2009 Feb;15(2):148-62. PubMedPMID: 19177435.
  2. Christophides T, Samstein B, Emond J, Bhagat G. Primary follicular lymphoma of the extrahepatic bile duct mimicking a hilar cholangiocarcinoma: case report and review of the literature. Hum Pathol. 2009 Dec;40(12):1808-12. Epub 2009 Aug 27.
  3. Guarrera JV, Samstein B, Goldstein MJ, Arrington B, Dorritie R, Lapointe-Rudow D, Renz JF, Emond JC. Digital imaging of extended criteria donor livers to facilitate placement and utilization. Prog Transplant. 2010 Mar;20(1):14-7.
  4. PubMed PMID: 20397341. Zhang Y, Zhang XM, Prowda JC, Zhang HL, Sant’anna Henry C, Shih G, Emond JC, Prince MR. Changes in hepatic venous morphology with cirrhosis on MRI. J Magn Reson Imaging. 2009 May;29(5):1085-92. PubMed PMID: 19388123.
  5. Verna EC, De Martin E, Burra P, Neri D, Gaglio PJ, Emond JC, Brown RS Jr. The impact of hepatitis C and biliary complications on patient and graft survival following liver transplantation. Am J Transplant. 2009 Jun;9(6):1398-405. Epub 2009 May 20. PubMed PMID: 19459805158.
  6. Zeng S, Dun H, Ippagunta N, Rosario R, Zhang QY, Lefkowitch J, Yan SF, Schmidt AM, Emond JC. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J 2009 May;50(5):929-36. Epub 2009 Jan 14. PubMed PMID: 19303658.
  7. Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl. 2009 Feb;15(2):148-62. PubMed PMID: 19177435.
  8. Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault NA; A2ALL Study Group. Incidence and severity ofacute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant. 2009 Feb;9(2):301-8. Epub 2008 Dec 15. PubMed PMID: 19120082.
  9. Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS Jr, Terrault NA, Hayashi PH, Hong JC; A2ALL Study Group. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg. 2010 Mar;251(3):542-9. PubMed PMID: 20130466.
  10. Guarrera JV, Henry SD, Chen SW, Brown T, Nachber E, Arrington B, Boykin J, Samstein B, Brown RS Jr, Emond JC, Lee HT. Hypothermic Machine Preservation Attenuates Ischemia/Reperfusion Markers after Liver Transplantation: Preliminary Results. J Surg Res. 2010 Feb 21. [Epub ahead of print] PubMed PMID: 20451921.
  11. Guarrera JV, Henry SD, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein MJ, Ratner LE, Renz JF, Lee HT, Brown RS Jr, Emond JC. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010 Feb;10(2):372-81. Epub 2009 Dec 2. PubMed PMID: 19958323.
  12. Siegel AB, Wang S, Jacobson JS, Hershman DL, Lim EA, Yu J, Ferrante L, Devaraj KM, Remotti H, Scrudato S, Halazun K, Emond J, Dove L, Brown RS, Neugut AI. Obesity and Microvascular Invasion in Hepatocellular Carcinoma. Cancer Invest. 2010 Dec;28(10):1063-1069. PubMed PMID: 21077757.
  13. Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH. Steatohepatitic
hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in
hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol.2010 Nov;34(11):1630-6. PubMed PMID: 20975341.
  1. Egorova NN, Gelijns AC, Moskowitz AJ, Emond JC, Krapf R, Lazar EJ, Guillerme S, Kaplan HS, Greco G. Process of care events in transplantation: effects on the cost of hospitalization. Am J Transplant. 2010 Oct;10(10):2341-8. doi:10.1111/j.1600-6143.2010.03260.x. Epub 2010 Sep 14. PubMed PMID: 20840476.
  2. DiNorcia J, Moroziewicz DN, Ippagunta N, Lee MK, Foster M, Rotterdam HZ, Bao F, Zhou YS, Yan SF, Emond J, Schmidt AM, Allendorf JD. RAGE signaling
significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma. J Gastrointest Surg. 2010 Nov;14(11):1680-90. Epub 2010 Sep 8. PubMed PMID: 20824364.
  1. Guarrera JV, Henry SD, Chen SW, Brown T, Nachber E, Arrington B, Boykin J.Samstein B, Brown RS Jr, Emond JC, Lee HT. Hypothermic Machine Preservation Attenuates Ischemia/Reperfusion Markers after Liver Transplantation: Preliminary Results. J Surg Res. 2010 Feb 21. [Epub ahead of print] PubMed PMID: 20451921.
  2. Guarrera JV, Samstein B, Goldstein MJ, Arrington B, Dorritie R, Lapointe-Rudow D, Renz JF, Emond JC. Digital imaging of extended criteria donor livers to facilitate placement and utilization. Prog Transplant. 2010 Mar;20(1):14-7.
  3. Findlay JY, Fix OK, Paugam-Burtz C, Liu L, Sood P, Tomlanovich SJ, Emond J.Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl. 2011 May;17(5):496-510. doi: 10.1002/lt.22269. PubMed PMID: 21506240
  4. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, Shaked A, Christie JD. Validation of a current definition of early allograft dysfunction in
         liver transplant recipients and analysis of risk factors. Liver Transpl. 2010
  1. Olthoff KM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, Tong L; and the A2ALL Study Group. Outcomes for adult living donor liver transplantation: Comparison of A2ALL and national experience. Liver Transpl. 2011 Feb 25. doi:10.1002/lt.22288.
  2. Wagener G, Minhaz M, Mattis FA, Kim M, Emond JC, Lee HT. Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant. 2011 May;26(5):1717-23. Epub 2011 Jan 21. PubMed PMID: 21257679.
  3. Wagener G, Kovalevskaya G, Minhaz M, Mattis F, Emond JC, Landry DW. Vasopressin Deficiency and Vasodilatory State in End-Stage Liver Disease. J Cardiothorac Vasc Anesth. 2010 Nov 30.
  4. Siegel AB, Wang S, Jacobson JS, Hershman DL, Lim EA, Yu J, Ferrante L, Devaraj KM, Remotti H, Scrudato S, Halazun K, Emond J, Dove L, Brown RS Jr, Neugut AI. Obesity and microvascular invasion in hepatocellular carcinoma. Cancer Invest. 2010 Dec;28(10):1063-9.
  5. Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS Jr,Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2011 Apr;17(4):409-17
  6. Zeng S, Zhang QY, Huang J, Vedantham S, Rosario R, Ananthakrishnan R, Yan SF, Ramasamy R, Dematteo RP, Emond JC, Friedman RA, Schmidt AM. Opposing roles of RAGE and Myd88 signaling in extensive liver resection.
  7. Verna EC, Farrand ED, Elnaggar AS, Pichardo EM, Balducci A, Emond JC, Guarrera JV, Brown RS Jr. Basiliximab induction and delayed calcineurin inhibitor initiation in liver transplant recipients with renal insufficiency.
Transplantation. 2011 Jun 15;91(11):1254-60.
  1. Kluger MD, Guarrera JV, Olsen SK, Brown RS Jr, Emond JC, Cherqui D. Safety of Blood Group A2-to-O Liver Transplantation: An Analysis of the United Network of Organ Sharing Database. Transplantation. 2012 Sep 15;94(5):526-531.
  2. Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, Jacobson JS,
Hershman DL, C Verna E, Zaretsky J, Halazun K, Dove L, Brown RS Jr, Neugut AI, Kato T, Remotti H, Coppleson YJ, Emond JC. Diabetes, Body Mass Index, and Outcomes in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation. Transplantation. 2012 Sep 15;94(5):539-543. PubMed PMID: 22864187.
  1. Emond J. Reducing complications in pediatric liver transplantation: do wehave the answer? Am J Transplant. 2012 Sep;12(9):2267-8.
  2. Henry SD, Nachber E, Tulipan J, Stone J, Bae C, Reznik L, Kato T, Samstein B,
Emond JC, Guarrera JV. Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am J Transplant.2012 Sep;12(9):2477-86. doi: 10.1111/j.1600-6143.2012.04086.x. Epub 2012 May 17.
PubMed PMID: 22594953.
  1. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012 Jul;143(1):88-98.e3;
  2. Chang MS, Olsen SK, Pichardo EM, Heese S, Stiles JB, Abdelmessih R, Verna EC, Guarrera JV, Emond JC, Brown RS Jr. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core
antibody-positive donors. Liver Transpl. 2012 Jul;18(7):834-8. doi:
10.1002/lt.23429. PubMed PMID: 22422699.
  1. Watkins AC, Vedula GV, Horan J, Dellicarpini K, Pak SW, Daly T, Samstein B,
Kato T, Emond JC, Guarrera JV. The deceased organ donor with an « open abdomen »:proceed with caution. Transpl Infect Dis. 2012 Jun;14(3):311-5.
  1. Kato T, Lobritto SJ, Tzakis A, Raveh Y, Sandoval PR, Martinez M.GranowetterL, Armas A, Brown RS Jr, Emond J. Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries. Am J Transplant. 2012 May;12(5):1323-8.
  2. Tulipan JE, Stone J, Samstein B, Kato T, Emond JC, Henry SD, Guarrera JV.
  Molecular expression of acute phase mediators is attenuated by machine preservation in      human liver transplantation: preliminary analysis of effluent, serum, and liver biopsies. Surgery. 2011 Aug;150(2):352-60.
  1. Everson GT, Terrault NA, Lok AS, Rodrigo del R, Brown RS Jr, Saab S, Shiffman ML, Al-Osaimi AM, Kulik LM, Gillespie BW, Everhart JE; Adult-to-Adult Living DonorLiver Transplantation Cohort Study.A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver  transplantation. Hepatology. 2013 May;57(5):1752-62.
  2. Jeon J, Watkins A, Wagener G, Samstein B, Guarrera J, Goldstein M,    MeltzerJ,Kato T, Emond JC.Complex hepatectomy under total vascular exclusion of the liver: impact of ischemic preconditioning on clinical outcomes.World J Surg. 2013 Apr;37(4):838-46.
  3. Lobritto S, Kato T, Emond J.Living-donor liver transplantation: current
perspective.Semin Liver Dis. 2012 Nov;32(4):333-40.
  1. Chang MS, Olsen SK, Pichardo EM, Heese S, Stiles JB, Guarrera JV, Emond JC, Brown RS Jr.Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors.Liver Transpl.2013 Apr;19(4):462.
  2. Chang MS, Olsen SK, Pichardo EM, Stiles JB, Rosenthal-Cogan L,
BrubakerWD, Guarrera JV, Emond JC, Brown RS Jr.Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience. Transplantation. 2013 Apr 15;95(7):960-5.
  1. Wagener G, Raffel B, Young AT, Minhaz M, Emond J.Predicting earlyallograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.Liver Transpl. 2013 May;19(5):534-42.
  2. Tarallo PA, Smolowitz J, Carriero D, Tarallo J, Siegel A, Jia H, Emond
JC.Prevalence of high-risk human papilloma virus among women with hepatitis C  virus before liver transplantation.Transpl Infect Dis. 2013 May 6.
  1. Agrawal MD, Mennitt KW, Zhang H, Samstein B, Kato T, Emond JC, DutruelSP,
Thimmappa ND, Prince MR. Morphine three-dimensional T1 gadoxetate MR
cholangiography of potential living related liver donors. J Magn ResoImaging.
2014 Mar;39(3):584-9..
  1. Freeman J, Emond J, Gillespie BW, Appelbaum PS, Weinrieb R, Hill-CallahanP,
Gordon EJ, Terrault N, Trotter J, Ashworth A, Dew MA, Pruett T; A2ALL Study
Group. Computerized assessment of competence-related abilities in livinliver
donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort StudyClin Transplant. 2013 Jul-Aug;27(4):633-45.
  1. Samstein B, Cherqui D, Rotellar F, Griesemer A, Halazun KJ, Kato T, Guarrera
J, Emond JC. Totally laparoscopic full left hepatectomy for living donor liver
transplantation in adolescents and adults. Am J Transplant. 2013
Sep;13(9):2462-6.
  1. Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown RS Jr, CameronA, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond JC, Stiles JB, Lukose T,Chang MS, Klintmalm G. Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity. Clin Transplant. 2013 Sep 3.
  2. Emond JC, Kluger MD. International perspectives on advanced liver surgery.
Semin Liver Dis. 2013 Aug;33(3):187-8.
  1. Lee SY, Mooney MA, Inra ML, Juluru K, Fox AN, Olsen SK, Brown RS Jr, EmondJC,Cherqui D, Kluger MD. Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and post-operative period: A cause for concern.
Hepatology. 2013 Jul 31. doi: 10.1002/hep.26633.
  1. Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A,
Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, LukoseT,Chang
M, Klintmalm G. Liver transplantation for hepatitis B liver disease and
concomitant hepatocellular carcinoma in the United States With hepatitis B
immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl. 2013
Sep;19(9):1020-9.
  1. Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff
KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL StudyGroup.
Hepatitis C disease severity in living versus deceased donor liver transplant
recipients: an extended observation study. Hepatology.2014Apr;59(4):13119.
  1. Kluger MD, Halazun KJ, Barroso RT, Fox AN, Olsen SK, Madoff DC, Siegel AB,
Weintraub JL, Sussman J, Brown RS Jr, Cherqui D, Emond JC. Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transpl. 2014 May;20(5):536-43.
  1. Graham JA, Samstein B, Emond JC, Kato T. Functional distal splenorenal shunt and splenic artery ligation as portal flow modulation in left lobe living donor transplantation. Liver Transpl. 2014 Feb;20(2):245-6.
  2. Chang MS, Stiles JB, Lukose TS, Balducci A, Brubaker WD, Burman BE, Emond JC, Brown RS Jr. Adherence to hepatitis B immunoglobulin (HBIG) after liver
transplantation. Transplantation. 2013 Dec 15;96(11):e84-5.
  1. Siegel AB, Goyal A, Salomao M, Wang S, Lee V, Hsu C, Rodriguez R, Hershman DL, Brown Jr RS, Neugut AI, Emond J, Kato T, Samstein B, Faleck D, Karagozian R. Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients. Oncology. 2014 Oct 3;88(1):57-68.
  2. Halazun KJ, Patzer RE, Rana AA, Verna EC, Griesemer AD, Parsons RF, Samstein B, Guarrera JV, Kato T, Brown RS Jr, Emond JC. Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology. 2014 Jun 20. doi: 10.1002/hep.27272.
  3. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR. An evaluation of the sensitivity of MRI at detecting hepatocellular carcinoma in cirrhotic patients utilizing an explant reference standard. Clin Imaging. 2014 Sep-Oct;38(5):693-7.
  4. Emond JC, de Ville de Goyet J. Hepatic venous reconstruction as the stake of
the liver: technical note and thoughts. Pediatr Transplant. 2014 Aug;18(5):420-2.
  1. Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, Freise CE,Gillespie BW, Everhart JE. Liver regeneration after living donor transplantation: Adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2014 Jul 28. doi: 10.1002/lt.23966.
  2. Halazun KJ, Rana AA, Patzer RE, Samstein B, Brown RS, Emond JC. Re: – Waiting time and transplantation for hepatocellular cancer: A balancing between tempus fugit and carpe diem. Hepatology. 2014 Sep 11. doi: 10.1002/hep.27435
  3. Emond JC, Fisher RA, Everson G, Samstein B, Pomposelli JJ, Zhao B, Forney S,
Olthoff KM, Baker TB, Gillespie BW, Merion RM. Changes in liver and spleen
volumes after living liver donation: a report from the Adult-to-Adult Living
Donor Liver Transplantation Cohort Study (A2ALL). Liver Transpl. 2015
Feb;21(2):151-61.
  1. Halazun KJ, Rana AA, Patzer RE, Samstein B, Brown RS Jr, Emond JC.
Hepatology. 2015 Apr;61(4):1439. doi: 10.1002/hep.27435. Epub 2015
Mar 9. PubMed PMID: 25209329.
  1. Guarrera JV, Henry SD, Samstein B, Reznik E, Musat C, Lukose TI, Ratner LE,
Brown RS Jr, Kato T, Emond JC. Hypothermic machine preservation facilitates successful transplantation of « orphan » extended criteria donor livers. Am J Transplant. 2015 Jan;15(1):161-9. doi: 10.1111/ajt.12958. Epub 2014 Dec 17.
  1. Wang H, Griesemer AD, Parsons RF, Graham JA, Emond JC, Samstein B. Delayed gastric emptying after living donor hepatectomy for liver transplantation. Case Rep Transplant. 2014;2014:582183.
  2. Hsu CC, Goyal A, Iuga A, Krishnamoorthy S, Lee V, Verna EC, Wang S, Chen FN, Rodriguez R, Emond J, Berk P, Lefkowitch J, Dove L, Brown RS Jr, Siegel AB. Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort OfHepatocellular Carcinoma Patients. Clin Transl Gastroenterol. 2015 Feb 5;6:e74.
  3. Samstein B, Griesemer A, Cherqui D, Mansour T, Pisa J, Yegiants A, Fox AN,
Guarrera JV, Kato T, Halazun KJ, Emond J. Fully laparoscopic left-sided donor
hepatectomy is safe and associated with shorter hospital stay and earlier return  to work: A comparative study. Liver Transpl. 2015 Jun;21(6):768-73.
  1. Rosen CB, Emond JC. Living Donor Liver Transplantation in emergencies: Is ittime to say yes? Am J Transplant. 2015 Jun;15(6):1455-6.
  2. Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, Dove L, Jorde UP,
Takayama H, Emond J, Naka Y, Mancini D, Lefkowitch JH, Christian Schulze P.
Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. J Heart Lung Transplant. 2014 Dec 23. pii: S1053-2498(14)01504-6.
  1. Zuber J, Rosen S, Shonts B, Sprangers B, Savage TM, Richman S, Yang S, Lau SP, DeWolf S, Farber D, Vlad G, Zorn E, Wong W, Emond J, Levin B, Martinez M, Kato T, Sykes M. Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD. Am J Transplant. 2015 May 18. doi: 10.1111/ajt.13325.
  2. Halazun KJ, Najjar M, Abdelmessih RM, Samstein B, Griesemer AD, Guarrera JV,Kato T, Verna EC, Emond JC, Brown RS Jr. Recurrence After Liver Transplantationfor Hepatocellular Carcinoma: A New MORAL to the Story. Ann Surg. 2017 Mar;265(3):557-564.
  3. Emond JC. Laparoscopic Donor Hepatectomy: A Way Forward? Transplantation. 2017Mar;101(3):468.
  4. Emond JC, Griesemer AD. Tolerance in clinical liver transplantation: The long
road ahead. Hepatology. 2017 Feb;65(2):411-413. doi: 10.1002/hep.28862.
  1. DiMartini A, Dew MA, Liu Q, Simpson MA, Ladner DP, Smith AR, Zee J, Abbey S,Gillespie BW, Weinrieb R, Mandell MS, Fisher RA, Emond JC, Freise CE, Sherker AH,  Butt Z. Social and Financial Outcomes of Living Liver Donation: A Prospective  Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort   Study 2 (A2ALL-2). Am J Transplant. 2016 Sep 20. doi: 10.1111/ajt.14055.
  2. Halazun KJ, Przybyszewski EM, Griesemer AD, Cherqui D, Michelassi F, Guarrera JV, Kato T, Brown RS Jr, Emond JC, Samstein B. Leaning to the Left: Increasing the Donor Pool by Using the Left Lobe, Outcomes of the Largest Single-center North American Experience of Left Lobe Adult-to-adult Living Donor Liver Transplantation. Ann Surg. 2016 Sep;264(3):448-56.
  3. Pomposelli JJ, Goodrich NP, Emond JC, Humar A, Baker TB, Grant DR, Fisher RA, Roberts JP, Olthoff KM, Gillespie BW, Merion RM. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience. Transplantation. 2016 Jul;100(7):1490-9.
  4. Emond JC. Live Donor Liver Transplantation: An International Perspective.
Transplantation. 2016 Jun;100(6):1182-3.
  1. Dew MA, DiMartini AF, Ladner DP, Simpson MA, Pomfret EA, Gillespie BW, Merion RM, Zee J, Smith AR, Holtzman S, Sherker AH, Weinrieb R, Fisher RA, Emond JC,Freise CE, Burton JR Jr, Butt Z. Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.  Transplantation. 2016 Jun;100(6):1257-69.
  2. Emond JC. Measuring access to liver transplantation: An overdue metric for
center quality and performance. J Hepatol. 2016 Apr;64(4):766-7.
  1. Weiner J, Griesemer A, Island E, Lobritto S, Martinez M, Selvaggi G,
Lefkowitch J, Velasco M, Tryphonopoulos P, Emond J, Tzakis A, Kato T. Longterm outcomes of auxiliary partial orthotopic liver transplantation in preadolescent children with fulminant hepatic failure. Liver Transpl. 2016 Apr;22(4):485-94.
  1. Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C,
Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F,  Nishida S, Gastaca M, Miró JM; FIPSE/NIH HIVTR/NEAT023 Investigators.. Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study. Am J Transplant. 2016 Feb;16(2):679-87.
  1. Wolf JH, Holmes MV, Fouraschen S, Keating BJ, Baker T, Emond J, Rader DJ,
Shaked A, Olthoff KM. Serum lipid expression correlates with function and regeneration following living donor liver transplantation. Liver Transpl. 2016 Jan;22(1):103-10.
  1. Matsuoka N, Weiner JI, Griesemer AD, Samstein BB, Zhao Y, Emond JC, KatoT.
Ex vivo pancreaticoduodenectomy and liver autotransplantation for pancreatic head tumor with extensive involvement of the hepatoduodenal ligament. Liver Transpl.2015 Dec;21(12):1553-6.
  1. Pereira MR, Scully BF, Pouch SM, Uhlemann AC, Goudie S, Emond JE, Verna
  2. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015 Dec;21(12):1511-9.
  1. Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA,
Burton JR Jr, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I Merion RM, Pomfret EA, Samstein B, Shaked A. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg. 2015
Sep;262(3):465-75; discussion 473-5
  1. Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke
CD, Verna EC, Dove L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, Brown RS Jr. Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma. Liver Cancer. 2015  Mar;4(2):115-25.
  1. Emond JC, Griesemer AD. Tolerance in clinical liver transplantation: The long
road ahead. Hepatology. 2017 Feb;65(2):411-413. doi: 10.1002/hep.28862.
  1. Emond JC. Laparoscopic Donor Hepatectomy: A Way Forward? Transplantation.
2017 Mar;101(3):468.
  1. Emond J. Commentary on: Temporary portal vein embolization is as efficient as
permanent portal vein embolization in mice. Surgery. 2017 Jul;162(1):82-83.
  1. Emond JC, Goodrich NP, Pomposelli JJ, Baker TB, Humar A, Grant DR, Abt P,
Friese CE, Fisher RA, Kam I, Sherker AH, Gillespie BW, Merion RM. Hepatic
Hemodynamics and Portal Flow Modulation: The A2ALL Experience. Transplantation.   2017 Oct;101(10):2375-2384.
  1. Griesemer AD, Emond JC. Big improvements for the smallest recipients. Liver
Transpl. 2017 Aug;23(8):997-998.
  1. Kadakia N, Lobritto SJ, Ovchinsky N, Remotti HE, Yamashiro DJ, Emond JC,
Martinez M. A Challenging Case of Hepatoblastoma Concomitant with Autosomal Recessive Polycystic Kidney Disease and Caroli Syndrome-Review of the Literature. Front Pediatr. 2017 Jun 7;5:114.
  1. Halazun KJ, Quillin RC, Rosenblatt R, Bongu A, Griesemer AD, Kato T, SmithC,Michelassi F, Guarrera JV, Samstein B, Brown RS Jr, Emond JC. Expanding theMargins: High Volume Utilization of Marginal Liver Grafts Among >2000 Liver Transplants at a Single Institution. Ann Surg. 2017 Sep;266(3):441-449.
  2. Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion RM. Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Liver
Transpl. 2017 Dec;23(12):1519-1530.
  1. Halazun KJ, Rana AA, Fortune B, Quillin RC 3rd, Verna EC, Samstein B,
Guarrera JV, Kato T, Griesemer AD, Fox A, Brown RS Jr, Emond JC. No country for
old livers? Examining and optimizing the utilization of elderly liver grafts. Am
J Transplant. 2018 Mar;18(3):669-678.
  1. Chaudhry SG, Bentley-Hibbert S, Stern J, Lobritto S, Martinez M, Vittorio J,
Halazun KJ, Lee HT, Emond J, Kato T, Samstein B, Griesemer A. Growth of liver
allografts over time in pediatric transplant recipients. Pediatr Transplant. 2018
Mar;22(2).
  1. Przybyszewski EM, Verna EC, Lobritto SJ, Martinez M, Vittorio JM, Fox AN,
Samstein B, Kato T, Griesemer AD, Emond JC. Durable Clinical and Immunologic
Advantage of Living Donor Liver Transplantation in Children. Transplantation.
2018 Jun;102(6):953-960.
  1. Elnaggar AS, Griesemer AD, Bentley-Hibbert S, Brown RS Jr, Martinez M,
Lobritto SJ, Kato T, Emond JC. Liver atrophy and regeneration in noncirrhotic
portal vein thrombosis: Effect of surgical shunts. Liver Transpl. 2018
Jul;24(7):881-887.
  1. Najjar M, Agrawal S, Emond JC, Halazun KJ. Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma. J HepatocellCarcinoma. 2018 Jan 18;5:17-28.
  2. American Society of Transplant Surgeons Executive Committee, Gaber O, Reed A, Pruett T, Emond J. Transplantation in value-based care for patients with renal
failure. Am J Transplant. 2018 Aug;18(8):2094-2095.
  1. Halazun KJ, Emond JC. Re: The Pursuit of Happiness. The thin line between
rights and duties. Am J Transplant. 2018 Jul;18(7):1828-1829.
  1. Halazun KJ, Tabrizian P, Najjar M, Florman S, Schwartz M, Michelassi F,
Samstein B, Brown RS Jr, Emond JC, Busuttil RW, Agopian VG. Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine
Hepatocellular Carcinoma Liver Transplantation Selection Policies. Ann Surg. 2018
Oct;268(4):690-699.
  1. Samstein B, Griesemer A, Halazun K, Kato T, Guarrera JV, Cherqui D, Emond JC. Pure Laparoscopic Donor Hepatectomies: Ready for Widespread Adoption? Ann Surg.2018 Oct;268(4):602-609.
  2. Carpenter DJ, Chiles MC, Verna EC, Halazun KJ, Emond JC, Ratner LE, Mohan S.Deceased brain dead donor liver transplantation and utilization in the United
States: nighttime and weekend effects. Transplantation. 2018 Nov 15.
Case Reports
  1. Rouch DA, Emond JC, Ferrari M, Yousefzadeh D, Whitington P, Broelsch CE.The successful management of portal vein thrombosis after hepatic transplantation with a splenorenal shunt. Surg Gynecol & Obstet 1988; 166; 311-316.
  2. Kommoss F, Emond JC, Hast J, Talerman A. Ruptured mature cystic teratoma of the ovary with recurrence in the liver and colon 17 years later: A case report.  JReproduct Med 1990; 35 (8): 827-831.
  3. Whitington PF, Emond JC, Heffron T, Thistlethwaite JR.Orthotopic liver transplantation for Crigler-Najjar Syndrome Type 1.  Lancet 1993; 342: 779-80.
  4. Abcarian PW, Emond JC, Ring EJ. Cystic duct remnant mucocele in a liver ransplantation recipient: definitive diagnosis by percutaneous aspiration and opacification. Journal of Vascular and Interventional Radiology, 1994 5 91): 27-30.
  5. Galler G; Yim A; Emond JC; Kirch E; Yousefzadeh D; Baker AL. Splenic arteriovenous fistula.   A Digestive Diseases and Sciences, 1996 Apr, 41 (4): 816-9.
  6. Shiva Kumar, Jay Lefkowitch, Mark W. Russo, Charles Hesdorffer, Milan Kinkhabwala, Sandip Kapur, Jean C. Emond, Robert S. Brown Jr. Successful sequential liver and stem cell transplantation for hepatic failure due to Primary AL-Amyloidosis .Gastroenterology. 2002 Jun;122(7):2026-31.
  7. Weyker PD, Allen-John Webb C, Emond JC, Brentjens TE, Johnston TA. Anesthetic implications of extended right hepatectomy in a patient with fontan physiology. A Case Rep. 2014 Apr 15;2(8):99-101. PMID: 25611770.
Book Chapters, Reviews, and Editorials:
  1. Bismuth H, Emond JC. “Bile duct tumors.” In: Current Surgical Therapy, Ed: Cameron J, BC Decker and Co., 1986.
  2. Bismuth H, Castaing D, Emond JC. “Intraoperative ultrasound and liver surgery”.  In: Surgery of the Liver and Biliary Tract. Ed: L. Blumgart, Churchill Livingstone, 1987: Edinburgh, UK.
  3. Broelsch CE, Emond JC. “Transplantation of Hepatic Segments”.  In: Progress in Surgery of the Liver, Pancreas and Biliary System. Ed: S. Bengmar MartinusNijhoff Pubs. 1988: Dorderecht, Boston, Lancaster.
  4. Rouch DA, Emond JC, Thistlethwaite JR, Broelsch CE. “Liver Transplantation forHepatic Malignancy”. In: Hepatobiliary and Pancreatic Malignancies Diagnosis, Medical and Surgical Therapy. Eds: Lygidakis, Tytgat, George Thieme Verlag, 1988: Stuttgart, New York.
  5. Broelsch CE, Emond JC, Rouch DA: “Prinzipien onkologischer Therapie bei primaren Lebertumoren”.  In: Prinzipien onkologischer Chirurgie, Hrsgb. G. Esser und H.  Imdahl, Georg Thieme Verlag, 1989: 86-92, Stuttgart, New York.
  6. *Emond JC, Whitington PF, Broelsch CE. “Reduced size liver transplantation: Techniques & clinical application .” In” TransplantatioImmunology  Letter,1989, 1989; VI (2).
  7. *Emond JC, Whitington PF, Broelsch CE. “Overview of reduced-size liver ”  Clin Trans 1991; 5 (2); 168-73.
  8. Whitington PF, Emond JC, Black DD, Whitington SH, Boone P, Smith C, Thistlethwaite JR, Broelsch CE. “Indications for liver transplantation in pediatrics.”  Clin Trans 1991; 5 (2): 155-60.
  9. *Emond JC. “Critical care of liver transplant patients”. In: Principles of Critical Care Medicine.  Hall JB, Schmidt GA, Wood LDH, Ed: McGraw-Hill,  1991:McGraw-Hill.
  10. Stevens LH, Piper JB, Heffron TG, Emond JC, Thistlethwaite JR, Whitington PF,Broelsch CE. The role of reduced-size liver transplantation in pediatric liver disease: Rationale and results.  In” Therapy in Liver Disease. Rodes J,  Arroya V,Ediciones Doyma: Barcelona   (In Press).
  11. Heffron TG, Emond JC.Segmental liver transplantation in children: Reducedizecadaveric, split and living related.  Transplantation Science: SurgicalTechniques and Complications 1992; 1 (2): 28-33.
  12. *Emond JC, Heffron TG.Living related liver transplantation:   Description of techniques.  In:  Atlas of Organ Transplant.  Ed: Flye W.,  W.B. Saunders, Philadelphia, PA 1995: 187-93.
  13. *Emond JC.The use of living-related donors for liver transplantation:  In:  Liver Transplantation Textbook Eds:   Wiesner R, Lake JR  (In press).
  1. Dimand R, Emond JC. Postoperative care management:   In: Transplantation of the Liver, W.B. Saunders Co., Philadelphia, PA 1996: 582-88.
  2. *Emond JC. Clinical application of living-related liver transplantation. In:Gastroenterology Clinics of North America, Ed: W.B. Saunders Co, Philadelphia, PA.  1993; 22 (2): 301-15.
  3. *Emond JC. Heffron TG.Living Related Liver Transplantation. In: Transplantation of the Liver, Vol. II. Ed: Maddrey W.J., Appleton & Lange.  1995: 97-107.
  4. Piper JB, Woodle ES, Newell KA, Whitington PF, Alonso, EM, Emond JC, Heffron TG, Broelsch CE, Thistlethwaite JR. Pediatric liver transplantation at the University of Chicago hospitals. Clinical Transplants, 1992: 179-89.
  5. *Emond JC, Renz JF. Surgical anatomy of the liver and its application to hepatobiliary surgery and transplantation.  Seminars in Liver Disease 1994; 14 (2):158-68.
  6. Heffron TG, Emond JC, Lloyd DM, Rogiers X. Whitington PE, Broelsch CE.Segmental orthotopic liver transplantation: Reduced size (RLT) liver transplantation.  In:  Pitfalls and complications in the diagnosis and management of hepatobiliary and pancreatic diseases.  Georg Thieme Verlag, Stuttgart, New York.  Eds:  Lygidakis NJ, et al: 1993.
  7. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation at the University of California, San Francisco. In:  Clinical Transplants 1993: 175-177.Terasaki and Cecka, Eds: UCLA Tissue Typing Laboratory, Los Angeles, CA.
  8. Xia R, Emond JC. Liver transplantation:  A new model with hepatic artery and bile duct anastomosis.  In:  Manual of Experimental Muscle Flap and Organ Transplantation  Models in the Rat. Eds: Zhang F, Lineaweaver WC, Kao SD, Walkjer R, Tonken H.  Stanford University Medical Center, Microsurgery Laboratory, Division of Plastic and Reconstructive Surgery.  Stanford, CA: 1996;77-9.
  9. *Emond JC. Surgical Techniques.  In: American Society Transplant Surgeons Primer on Transplantation.  Eds: Norman , Douglas J, MD and Wadi, Suki N, MD.(In press).
  10. *Emond JC, Lee R, Lim R. Prognostic Factors and Management of Carcinomas of the Gallbladder and Extrahepatic Bile Ducts.  Invited chapter:Surgical Oncology Clinics of North America, W.B. Saunders Co., Philadelphia, PA (In press July 1997)
  11. *Emond JC. Living-Related Liver Transplantation: Evaluation of Donors and Recipients. Selected Topics of Hepato-Pancreato-Biliary Surgery and Medicine IRCCS Policlinico San Matteo Pavia
  12. *Emond JC. Liver transplantation in children: Advances in patient selection, technique and immunosuppression.   Acta Pediatrica Sinica 1997; 38.
  13. Emond JC. Living Related Donor Liver Transplantation.   In:  Sorrell and Maddrey:   Transplantation of the Liver 3rd   Lippincott-Raven.   Philadelphia.    2001: 101-111.
  14. Kinkhabwala M and Emond JC.The Transplant Operation   in:  O”Grady,  Lake and Howdle.    Comprehensive Clinical Hepatology   Mosby International   2000 35.1-14.
  15. Emond JC and Marvin MReconstruction of the bile duct: Anatomic principals and surgical strategy.     in:  eds: Baker RJ and Fischer JE  “Mastery of Surgery”  Lippincott Williams and Wilkins  2001:1164-1171.
  16. Lobritto SJ and Emond JCPre-transplant evaluation of the recipient and donor.  in eds: Fine RL and Tejani A    Pediatric Transplantation Primer   Munksgaard,  International Publishers   Copenhagen  2000:253-265..
  17. Emond JC. Living related liver transplantation.      in:  eds: Norman DJ and Turka LA.    AST Primer on Transplantation Second Edition.     American Society of Transplantation  Portland OR    (In press,  2000).
  18. Marvin M and Emond JC.Cirrhosis and portal hypertension    in:  ed: Greenfield LJ.   “ Surgery: Scientific Principles and Practice” Lippincott Williams and Wilkins 2001: 957-988.
  19. Rosenthal J, Sussman J, Haskall Z Emond JC. Transjugular intrahepatic portosystemic shunts.        In:   ed: Cameron JL.    “Current Surgical Therapy” 7th  Mosby 2001:399-406.
  20. Samstein B, Emond J. Liver transplants from living related donors.   Annu Rev Med 2001;52:147-60
  21. Emond JC. Optimizing the donor pool: The status of split liver and living donor liver transplants 2001.   in Eds: Arroyo V et al.   “Therapy in Hepatology”  Ars Medica Spain  2001:317-323.
  22. Guarrera JV and Emond JC.Advances in segmental liver transplantation:  Can we solve the donor shortage? Transplant Proc. 2001 Nov;33(7-8):3451-5.
  23. Emond JC. What’s new in transplantation 2002. J Am Coll Surg. 2002 May;194(5):636-41.
  24. Haskal ZJ, Emond J, Brown R. Mesenteric venous thrombosis. N Engl J M 2002; 346: 1252.(Letter).
  25. Redai E, Emond J, Brentjens P.Anesthetic considerations during liver surgery.   Surg Clin NA.  2003 (In press).
  26. Pierre-Alain Clavien, MD, PhD, Jean Emond, MD, Jean Nicolas Vauthey, MD, Jacques Belghiti, MD, Ravi Chari, MD, and Steven M. Strasberg, MD. Protection of the Liver during Hepatic SurgeryJ Gastrointest Surg. 2003 (In press).
  27. Renz JF, Yersiz H, Reichert PR, Hisatake GM, Farmer DG, Ghobrial RM, Emond JC, Bussuttil RW. Split-Liver Transplantation: A Review.  J. Transplantation 2003; 3:1-13.
  28. John Allendorf, Nikalesh Ippagunta, Jean Emond. Management of Liver Metastases:  New Horizons for Biologically Based Therapy.  Surgical Research 2004 (In press).
  29. Emond JC. Living donor liver transplantation in children: what to recommend? (Editorial)  J. Transplantation 2004 Mar;4(3):293-4.
  30. Forman LM, Trotter JF, Emond J. Living donor liver transplantation and hepatitis C (Editorial). Liver Transpl. 2004 Mar;10(3):347-348.
  31. Jean Emond M.D. and Adam Griesemer MD Editorial Comment: Laparoscopy for cystic parasitic and non-parasitic disease of the liver. In: Controversies in Laparoscopic Surgery,Editors: M. Gagner, A. Assalia & M. Schein (In press).
  32. Renz JF, Reichart PR, Gordon S, Emond JC. Surgical anatomy of the liver In: Busuttil R and Klintmalm G eds.  Liver Transplantation  (In press).
  33. Lobritto SJ, Emond JC.Post-operative Care of Pediatric Liver Transplant Recipients. In: Busuttil R and Klintmalm G eds.  Liver Transplantation  (In press).
  34. Renz JF, Kin CJ, Saggi BH, Emond JC. Outcomes of living donor liver transplantation. In: Busuttil R and Klintmalm G eds.  Liver Transplantation  (In press).
  35. Emond JC. Reducing complications in pediatric liver transplantation: do we have the answer?Am J Transplant. 2012 Sep;12(9):2267-8.
 
 
Selected National and International Invited Lectures
“Hepatic Reduction: Techniques and results” University of Paris: Val de Marne Hopital Henri Mondor.  May 24, 1989.
“Evolution of partial hepatic transplantation”, University of Paris:  Hopital Cochin.May 15, 1989.
“Liver Transplantation in Children:  The University of Chicago experience,: Journees de Chirurgie Hepato-Biliaire, Paris. May 27, 1989.
“University of Chicago experience with reduced liver transplantation”. Université Catholique de Louvain. Brussels. November 29, 1990.
“Techniques de transplantation hepatique: le foie reduit, un foie pour deux et le donneur vivant”.  Journees de Chirugie Hepato-Biliaire Paris, France. May 11, 1990.
“Split Livers and live donors:  Application and techniques”, Euromedicine. Montpellier, France. November 7-11, 1990.
“Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants”. Post-graduate course, Clinique de Chirurgie Digestive.  Geneva, Switzerland, March 14-15, 1991.
“Il prelievo parziale di fegato da donatore volontarioe sano”. Chirurgia Epato-Biliare e Trapianto di Fegato.  Pavia, Italy.  July 4, 1991.
“Transplantation hepatique:  Donneur vivant”.  Journees de Chirurgie Hepato-Biliaire. Paris, France.  June 1991.
“Foie reduit & donneur vivant”. Hopital Beaujon. Beaujon, France.  June 1991.
“Foie reduit & donneur vivant”.  Hopital Henri Mondor.  Creteil, France. June 1991.
Visiting Professor, University of California-San Francisco, San Francisco California. November 1991.
Visiting Professor, Duke University Medical Center, Durham, North Carolina. February
Visiting Professor, Mayo Clinic, Rochester, Minnesota. February 1992.
“Transplantation hepatique en 1992. Perspectives”. Journees Francophones de Pathologie Digestive.  Paris France. March 18-April 1, 1992.
“Split liver et transplantation familiale”. 14emes Journees de Chirurgie.  Rennes, France.  April 3, 1992.
“Living related liver transplantation”. 29thAnnual Meeting of Japanese Society of Pediatric Surgeons.  Sapporo, Japan June 10-12, 1992.
“Surgical problems in pediatric liver transplantation”. 29thAnnual Meeting of Japanese Society of Pediatric Surgeons.  Sapporo, Japan June 10-12, 1992.
“The evolution of reduced size liver transplantation”. 17thAnnual Congress of Japanese College of Surgeons. Kyoto, Japan June 20, 1992.
“Living related liver transplantation”.  Visiting Professor, University of Orgeon (OHSU) Portland, Oregon. May 13, 1993.
Liver Transplantation program evaluation. Hôpital Sainte-Justine. Montreal, Quebec.
July 23, 1993.
“Reduced size liver transplantation”. First International Congress on Pediatric Transplantation.  Minneapolis, Minnesota.  August 29, 1993.
“Living related liver transplantation update”. American College of Surgeons Annual Clinical Congress.  San Francisco, California.  October 12, 1993.
“Alternatives to standard liver transplantation”. Liver Transplantation in the 1990’s.
University of Miami, Miami, Florida.  October 30, 1993.
“Living-related liver donation for liver transplantation”. Seventh International Workshop on Transplantation Cytology, Immunology & Histology.  Buenos Aires, Argentina.  November 26, 1993.
“Innovative techniques in liver transplantation”.  Visiting Professor University of Washington. Seattle, WA.  December 7, 1993.
“Selection & Timing in Living-related Liver Transplantation in Children”.  World Congress of Gastroenterology, Los Angeles, CA.  October 8, 1994.
“Reduced-size Liver Transplantation & General Surgery”. American College of Surgeons, Chicago, IL. October 11, 1994.
“Living-related.Liver Transplantation in Children”.  Visiting Professor University of Minnesota, Minneapolis, MN.  March 16, 1995.
“Ethical Issues & Advances in Transplantation”. Bioethics Beyond Borders Conference, University of California at Berkeley, California.  June 23-25, 1995.
“ Liver Transplantation:  The Living Donor”. 2ndAlps-Adria Congress on Hepato-Pancreato-Biliary Surgery & Medicine.  Pavia, Italy.   September 13-16, 1995.
“Liver Transplantation:  The Living Donor”.  Ospedale Maurizziano “Umberto I”
di Torino, Multidisciplinary Special Lecture. Turin, Italy, September 19, 1995.
“Liver Transplantation in Children”.  American College of Surgeons, New Orleans, LA. October 24, 1995.
‘The Liver Transplant Evaluation: Linking Risk Factors & Outcome: ILTS/American Association for the Study of Liver Diseases Postgraduate Course, Chicago, IL. November 3, 1995.
“Liver Transplantation for Inherited Liver Disorders”. American Association for the Study of Liver Diseases Postgraduate Course, Chicago, IL. November 5, 1995.
“Living related liver transplantation: The UCSF Experience”.  International Symposium on Living-related liver transplantation, Kaohsiung Hsien, Taiwan. January 6, 1996.
“Strategies for Tolerance Induction: Potential Applications in Living Donor Transplantation”.  International Symposium on Living related Liver Transplantation, Kaohsiung Hsien, Taiwan.  January 6, 1996.
“Liver Transplantation in Children”.  Pediatric Grand Rounds.  Primary Children’s Hospital University of Utah. February 1, 1996.
“Quality of Life in the Pediatric Liver Transplant Program”. Society of Gastroenterology Nurses and Associates, Inc. 23rdAnnual Course, May 20, 1996.
“Living related liver transplantation for fulminant hepatic failure”.  Symposium on liver transplantation.  American Society of Transplant Physicians, Dallas Texas. May 1996.
“Recurrent Liver Disease after Liver Transplantation”. International Liver Transplant Society Course at the American Society for the Study of Liver Diseases 47thAnnual Meeting, Chicago, IL. November 8th-11th, 1996.
‘Three Dimensional Anatomy of the Left Bile Duct: Implications for Living Donors” The American Society for the Study of Liver Diseases 47thAnnual Meeting, Chicago, IL. November 8th-11th1996.
“Quality of Life in the Pediatric Liver Transplant Patient” Advances in Tranplantation 8thAnnual Conference, San Francisco, California November 17-20, 1996.
“Living Related Transplant in Adults: Multi-center Experience “Contemporary Forums”  Advances in Transplantation 8thAnnual Conference San Francisco, California, November 17-20, 1996.
“Anatomy of the Left Bile Duct- The Living Replated Donor”. First Americas Hepato-Pancreato-Biliary Congress, Miami, Florida February 23, 1997.
“Pediatric Liver Transplantation:  Latest Advances in Immunosuppression and Technical Innovations”.  5thAnnual Congress Asian Pan Pacific Society of Pediatric GI and Nutrition (APPSPGN) Taipei, Taiwan April 9th-14th1997.
“The Use of Live Donor Transplantation in Adults and Children with Fulminant Failure” The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina April 17, 1997.
“Update in Liver Transplantation” Surgical Grand Rounds: Columbia-Presbyterian Medical Center, New York,NY, July 10, 1997
“Update in Liver Transplantation” Special Guest Lecture: The Babies and Children’s Hospital of New York. Pediatric Grand Rounds September 19, 1997.
“Anatomie en trois dimensions du canal hépatique gauche: implications pour les donneurs vivants”.   99e Congrês Francais de Chirùrgie , Paris, France, October 6-8, 1997.
“La réexploration planifiée des receveurs de greffons hépatiques pédiatriques réduit la morbidité après greffe et diminue la durée totale d’hospitalisation. 99eCongrês Francais de Chirùrgie, Paris, France, October 6-8, 1997.
 “Introduction to the Joint Liver Transplant Program at Cornell and Columbia”.Guest Lecture:   Dean’s Hour, New York Hospital-Cornell Medicall Center, October 29, 1997.
Liver transplantation for hepatoblastoma.    Children’s Cancer Group Meeting.
Houston TX.   April 24,1998.
Liver transplantation and scarce resources. Ethics symposium.   American College of Surgeons.   Clinical Congress.    Orlando, FL.   Oct 28,  1998.
“Liver transplantation and the media.”  American Society of Medical Writers Conference.
New York,  NY    Oct. 1998.
“Living liver donors in adults: the case against”  ASTS/AST joint symposium.
Chicago     May 19,1999.
Liver transplantation for primary hepatic malignancy.     Meet the professor session.
American Society of Clinical Oncology.    Annual Meeting    New Orleans.  May 2000.
Split Liver Transplantation: ex-situ vs in-situ.  Invited lecture.   International Congress of the Transplantation Society.   Rome IT     Aug.   2000.
Clinical trials with small n:  The development of living related liver transplantation.  Special Conference of the Institute of Medicine.    Washington DC.    Sept. 28,2000.
Segmental liver transplantation in children and adults. NIH consensus conference on living related liver transplantation.    Dec. 2001.
Le split et les greffons petits pour taille.  Plenary lecture.    3rdCongress of the Society Francophone de Transplantation    Geneve, Suisse   Dec. 2001.
Liver transplantation from living donors: The recipient operation.   5thpostgraduate course on Transplantation    Universita di Roma   Rome It  Mar. 6,2001.
Co chair,  Liver work group      Extended use of cadaver donors:  ASTS/AST consensus conference    Crystal City MD    April 2001.
Extending the donor pool: Split livers and optimal use.  Plenary Lecture
Transplant 2001,     Chicago IL.    May 12. 2001.
Advances in segmental liver transplantation:  Can we solve the donor shortage?     Internation Transplantation Congress.. Istambul  Aug 01.
Biology of the small liver.    Visiting Professor University of Rochester.  Rochester NY
Dec. 05,2001.
Ethical issues in living related liver transplantation. Clinical symposium.  Digestive Disease Week.   San Francisco CA.  May 20, 2002.
Liver Transplantation in Children,   Pediatrics in Review   Columbia University   New York  NY    Sept 27, 2002
The Future of Liver Replacement.    ATS  Annual Postgraduate Course.  Naples, FL
Jan 20,  2003
Liver transplantation in the United States: Liver transplantation consensus conference for France. Lyon, France  Feb. 2005.
Long term results in liver donors.  International conference of living donor liver transplant.  Essen FRG.  Sept 2005.
History of living donor liver transplantation. Grand rounds  University of Maryland.
Baltimore MD.   Dec. 2005.
Living donor liver transplantation.   Grand rounds.   University of Virginia.   April 2006.
Update on liver transplantation in the United States.  International Hepatobiliary Congress.  HB Society  London UK.  May 2006.
Le donneur vivant dans la transplantation hepatique.  Academie de Chirurgie.  Paris FR.  May 2006.
Le donneur vivant dans la transplantation pediatrique.  Reunion Hopital Necker. Universite de Paris.   May 2006.
Long term results of adult to adult living donor liver transplants.  World Transplant Congress.  Boston MA. July 2006.
Use of extended criteria donors.  International Congress of IHBPA,  Edinburgh UK.  Sept. 06.
Use of DCD donors.  Controversies in Liver Transplantation  Breckinridge CO,  March 2007.
Biliary complications in liver transplantation.  Postgraduate course.   American College of Surgeons.   Chicago.   Oct. 2006.
Liver transplantation for Hepatocellular Carcinoma AHPBA,  Las Vegas  April 2007.
History of liver transplantation for hepatocellular carcinoma     Post Graduate Course, Hepatobiliary Surgical Association,  Lisbon   May 2007.
Living Donor Liver Transplantation in North America,  Essen FRG,  June 2007.
Long Term Follow-up of Recipients: Liver, Essen FRG, June 2007.
Living donors and split livers.  Controversies in Liver Transplantation  Breckinridge CO,  March 2008.
Update on A2ALL study.  American Transplant Congress,  Toronto CA, May 2008.
Living donor liver transplantation.   Hepatobiliary surgery course. Imperial College London UK. Sept 2008.
Liver transplantation for Hepatocellular Cancer.  International transplant meeting. Warsaw University.  Warsaw Poland Oct 2008.
Advances in Liver Transplantation.  Visiting Professor,  Chang Gung Memorial Hospital.  Kaohsiung,  Taiwan Dec. 2008.
Liver transplantation for Hepatocellular Cancer.  Advances in the treatment of Hepatitis C Taipei, TW  Dec. 2008.
Surgical therapy of Hepatocellular Carcinoma in Children.   Internation Liver Cancer Meeting.  Seoul KO.  Dec.  2008.
Pediatric transplantation:  Arab medical congress.  Dubai UAR Jan 2009.
Living donor liver transplantation: Patterns of graft failure. Controversies in Liver Transplantation  Breckinridge CO,  March 2009.
L’Evolution des contre-indications dans la transplantation hepatique.  International Hepato-biliary congress 2009.  Geneva SW.  May 2009
Surgical development of partial liver transplantation 1985-92. CMC-20 Anniversary First Pediatric Living Donor Liver Transplant Celebration   Chicago, IL Oct. 2009.
Extending the limits of hepatectomy.   Surgical biology club II.   Chicago IL  Oct 2009.
A2ALL principal findings: the US experience. International transplant meeting Brussels Dec. 2009
Left Lobe and Beyond.   International Transplant Meeting  Cairo. Egypt  Mar 2010
Allocation and Extended Donors   UNOS Consensus Conference   Atlanta May 2010
Living Donor Liver Transplantation in Children ATC San Diego CA June 2010
Near Miss in a Living Donor ATC San Diego CA June 2010
Living Donor Liver Transplantation: Surgical Grand Rounds U of Maryland. Oct 2010
Small for Size Syndrome: Natural History AASLD Boston MA Oct 2010.
Living donor liver transplantation.   Asia Pacific Summit-Busan, Korea-January 21-22, 2011
Visiting professor: Mass General Hospital, Living donor liver transplantation.  Bost MA. Feb. 2011.
Left lobe liver transplantation, the real data.   Controversies in Transplantation-Breckenridge, Co March 3-6, 2011
2013Left lobe liver transplantation. International Hepatobiliary Congress. Jerusalem May 2011.
Use of extended criteria livers.   ASTS 12thWinter Symposium Miami, FL January 12-15, 2012
Living donors for Hepatocellular carcinoma.   Controversies in Transplantation Breckenridge, CO March 1-4, 2012
Living donor liver transplantation: Innovations.   5thAnnual Olga Jonasson Symposium-Chicago, IL May 31-June 1, 2012
Aduit en Transplantation a Bruxelles-Brussels, Belgium June 18-19, 2012
Machine perfusion of the liver for transplantation.    10thWorld Congress of IHPBA Paris, France July 1-5, 2012
Technical innovations in liver transplantation.   Lisa Landress foundation 2012 Visiting Professor in Transplantation Baylor October 24, 2012
Selection of donors in liver transplantation, when to say yes.  ASTS 13thAnnual Winter Symposium Miami FL January 31-February 3, 2013
Lempert Visiting Professorship.   Advances in hepatobiliary surgery. Albany Medical Center, NY June 13, 2013
International Symposium on Precision Liver Surgery.  Biology of Portal thrombosis.  Beijing China.  May 2013.
Visiting Professor of Surgery; Surgery and Biology of Cholangiocarcinoma PLA General Hospital Beijing, China  Nov. 2013
Roth Visiting Professorship, McGill University, Surgery and biology of Portal thrombosis,   Living donor liver transplantation, State of the Art.    Montreal, CA   Nov. 2013.
Combined Liver and Renal Transplantation.  Controversies in Transplantation.  University of Colorado, Breckinridge CO Feb 2014.
Visiting Professor, University of Nebraska, Omaha NE  Feb. 2014.
Visiting Professor, UCSD.  Surgery and Biology of Living Donor Liver Transplantation, San Diego, May 2014.
International Hepatobiliary Symposium:  Early Transplantation for HCC Reduces Survival.  Coimbra, Portugal.  May 2014.
Left lobe outcomes: The Western perspective.   World Transplant Congress.  San Francisco, CA  August 2014.
Portal Flow in Living Donor Liver Transplantation.   World Transplant Congress.  San Francisco, CA  August 2014.
Left lobe in Living Donor Liver Transplantation.   7thAnnual Living donor Abdominal Transplantation Conference.   Padova Italy.   September 2014.
Liver donor liver transplantation for Hepatocellular Carcinoma.  Il Tumore Di Fegato.   Corso Di Aggiornamento.   Milan Italy  November 2014.
The Starzl Lecture: Living donor liver transplantation, Has it fulfilled its promise?  AASLD.
Boston MA  Nov. 2014.